000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1462|2824|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|Risperídón||1462||1462|2824 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|6747|9996|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6747||6747|9996 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|43271|55740|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|Epóetín||43271||43271|55740 000055|B03XA0103|NeoRecormon|sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|129541|163146|lyfsjukr|||00|1|0|60|Icepharma hf|Roche|Epóetín||129541||129541|163146 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|64804|82548|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|Epóetín||64804||64804|82548 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10940|15687|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||10940||10940|15687 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|1653|3084|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||1653||1653|3084 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|3812|6013|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||3812||3812|6013 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|32552|42712|lyfalmen|||00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||32552||32552|42712 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|42334|54891|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||42334||42334|54891 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21298|28701|lyfalmen|V0813|28171|00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||21298||21298|28701 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|9813|14157|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||9813||9813|14157 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|6233|8924|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|Atosíban||6233||6233|8924 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|8009|15427|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||8009||8009|15427 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|17140|23207|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|Atosíban||17140||17140|23207 000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1729|3187|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1729||1729|3187 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|21329|28740|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||21329||21329|28740 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5665|8111|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Elektrólýtar||5665||5665|8111 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|42309|54860|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|Follitrópín beta||42309||42309|54860 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5622|8470|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|Rizatriptan||5622||5622|8470 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3114 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3357|5396|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3357|5396 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|29494|38905|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||29494||29494|38905 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2064|3641|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||2064||2064|3641 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5477|8273|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||5477||5477|8273 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4342|6733|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|Tópíramat||4342||4342|6733 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5656|8516|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5656||5656|8516 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|15764|21494|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Fitusambönd||15764||15764|21494 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4828|7392|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||||4828|7392 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||2590||2590|3708 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3993|6259|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||3993||3993|6259 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|2|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|174085|218603|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|Interferón beta-1a||174085||174085|218603 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|14688|20472|lyfalmen|||00|60|0|30|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||14688||14688|20472 000957|H01AC0101|Genotropin|sts|0| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|35923|46592|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||35923||35923|46592 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6663|9540|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|Ganirelix||6663||6663|9540 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1808|3294|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||1808||1808|3294 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12474|17715|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12474||12474|17715 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|23870|31903|lyfalmen|||00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||23870||23870|31903 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2423|4129|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|Metóprólól||2423||2423|4129 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|12400|17623|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||12400||12400|17623 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|425874|532081|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||425874||425874|532081 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|4911|7505|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||4911||4911|7505 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|1177|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis hf|Simvastatín||248||248|1177 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|34218|44469|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|Ganirelix||34218||34218|44469 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis hf|Simvastatín||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|Simvastatín||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|V0362|2265|00|98|0|65|Actavis Group hf|Actavis hf|Simvastatín||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|2685|00|98|0|131|Actavis Group hf|Actavis hf|Simvastatín||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|7024|10372|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||7024||7024|10372 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4704|7224|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4704||4704|7224 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4173 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|28221|37003|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|Blöndur||28221||28221|37003 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|VIF|0|0|1|100|CHF|13901|19492|lyfalmen|V0011|19492|00|25|0|5|Vistor hf|Vifor France SA|Járnoxíð (sykurflétta)||13901||13901|19492 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38246|49484|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|Blöndur||38246||38246|49484 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|25953|34179|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|Blöndur||25953||25953|34179 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|7289|10436|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|Albúmín||7289||7289|10436 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|11640|16359|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|Albúmín||11640||11640|16359 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Vistor hf|Bayer A/S|Acetýlsalicýlsýra||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1366|1956|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1366||1366|1956 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4301|6677|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|Brinzólamíð||4301||4301|6677 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1085|2313|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1085||1085|2313 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|81231|103000|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín, lamívúdín og abacavír||81231||81231|103000 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4634|7129|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|Capsaicin||4634||4634|7129 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5475|8270|lyfalmen|V0793|8270|00|60|0|24|Actavis Group hf|Actavis hf|Risperídón||5475||5475|8270 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9485|13712|lyfalmen|V0456|13590|43|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||9485||9485|13712 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3918|6157|lyfalmen|V0084|6157|00|28|0|19|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3918||3918|6157 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7657|11231|lyfalmen|||0|56|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7657||7657|11231 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1431|2782|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1431||1431|2782 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5360|8114|lyfalmen|V0085|7999|00|28|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5360||5360|8114 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|4909|7502|lyfalmen|||00|100|0|27|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4909||4909|7502 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22536|29925|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|Blöndur||22536||22536|29925 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6552|9732|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6552||6552|9732 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|20156|26962|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|Blöndur||20156||20156|26962 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32982|42930|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|Blöndur||32982||32982|42930 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13479|18966|lyfalmen|V0087|18966|00|100|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13479||13479|18966 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8549|12442|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8549||8549|12442 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|4115|6425|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|Insúlín aspart||4115||4115|6425 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19106|25972|lyfalmen|V0089|25593|00|100|0|133|Vistor hf|AstraZeneca A/S DK|Esómeprazól||19106||19106|25972 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4377|6780|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||4377||4377|6780 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7157|10553|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||7157||7157|10553 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7500|11018|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|Kalcípótríól||7500||7500|11018 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4366|6765|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|Kalcípótríól||4366||4366|6765 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|18139|24768|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|Montelúkast||18139||18139|24768 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|104717|132240|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||104717||104717|132240 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|52601|67356|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||52601||52601|67356 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|30152|39407|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||30152||30152|39407 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2812|4656|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||2812|4656 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1532|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|Enalapríl||510||510|1532 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2812|4656|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||2812||2812|4656 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Lóratadín||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Lóratadín||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3662|lyfalmen|V0984|3662|00|100|0|100|Actavis Group hf|Actavis hf|Lóratadín||2079||2079|3662 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|208701|261700|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||208701||208701|261700 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|3029|5242|vetorma|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||3029|5242 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1444|2800|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|Tímólól||1444||1444|2800 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|30811|40227|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||30811||30811|40227 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|67338|86021|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|Follitrópín alfa||67338||67338|86021 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|14991|15952|lyfalmen|V0193|15952|00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||11136||11136|15952 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|14163|19818|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|Levetíracetam||14163||14163|19818 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|293506|367282|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||293506||293506|367282 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|19155|26033|lyfalmen|V1710|26033|00|100|0|25|Vistor hf|U.C.B|Levetíracetam||19155||19155|26033 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|37219|48523|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Levetíracetam||37219||37219|48523 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|9050|13122|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||9050||9050|13122 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|13501|18994|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||13501||13501|18994 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|19769|26480|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|Darbepóetín alfa||19769||19769|26480 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|29451|38534|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|Darbepóetín alfa||29451||29451|38534 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|30670|40052|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|Darbepóetín alfa||30670||30670|40052 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|45342|58318|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|Darbepóetín alfa||45342||45342|58318 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|59403|75824|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|Darbepóetín alfa||59403||59403|75824 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|73264|93081|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|Darbepóetín alfa||73264||73264|93081 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|211467|265144|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||211467||211467|265144 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8298|12101|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8298||8298|12101 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|87987|111411|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|Darbepóetín alfa||87987||87987|111411 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7583|11131|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7583||7583|11131 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|116014|146305|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|Darbepóetín alfa||116014||116014|146305 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|69770|89049|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|Sirolimus||69770||69770|89049 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|143150|180089|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|Darbepóetín alfa||143150||143150|180089 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|213999|268296|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|Darbepóetín alfa||213999||213999|268296 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|107047|135141|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||107047||107047|135141 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4384|6790|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||4384||4384|6790 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3765|5950|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Mísóprostól||3765||3765|5950 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|14713|20503|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||14713||14713|20503 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|6740|9987|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||6740||6740|9987 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|22533|30239|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||||22533|30239 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|930|2102|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||930||930|2102 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1170|2428|lyfalmen|V0931|2428|00|28|0|28|Actavis Group hf|Actavis hf|Sertralín||1170||1170|2428 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|679|1762|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|Díklófenak||679||679|1762 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4068|6361|lyfalmen|V0933|6361|00|98|0|98|Actavis Group hf|Actavis hf|Sertralín||4068||4068|6361 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|100218|126639|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|Lopinavír||100218||100218|126639 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2269|3920|lyfalmen|V0608|2082|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2269||2269|3920 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|35343|45870|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||35343||35343|45870 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8442|12297|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8442||8442|12297 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|4202|6543|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4202||4202|6543 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|632|1698|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||632||632|1698 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|1130|2374|lyfalmen|||10|30|0|15|Vistor hf|Meda AB|Flúrazepam||1130||1130|2374 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6596|9791|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||6596||6596|9791 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|6131|9160|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||6131||6131|9160 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|8534|12421|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8534||8534|12421 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|800|1926|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Deslóratadín||800||800|1926 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6322|9420|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|Mirtazapín||6322||6322|9420 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|23729|31410|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||23729||23729|31410 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1766|3237|lyfalmen|V1901|3237|00|30|0|30|Vistor hf|Schering-Plough|Deslóratadín||1766||1766|3237 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|8541|12431|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||8541||8541|12431 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|4940|7544|lyfalmen|V1902|7544|00|100|0|100|Vistor hf|Schering-Plough|Deslóratadín||4940||4940|7544 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4871|9450|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||4871||4871|9450 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3463|5540|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |Tramadól||3463||3463|5540 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|661|1737|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|Ísósorbíð dínítrat||661||661|1737 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3403|5458|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3403||3403|5458 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4619|7109|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |Tramadól||4619||4619|7109 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|35032|45482|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|Tegafur||35032||35032|45482 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6524|9694|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |Tramadól||6524||6524|9694 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8684|12625|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |Tramadól||8684||8684|12625 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2031|3597|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2031||2031|3597 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|58386|74558|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|Tegafur||58386||58386|74558 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|70063|89096|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|Tegafur||70063||70063|89096 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|46709|60020|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|Tegafur||46709||46709|60020 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4385|6791|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |Glímepíríð||4385||4385|6791 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|39481|51021|lyfsjukr|||00|1|0|4|MedFarm ehf|E. Merck AB|Sómatrópín||39481||39481|51021 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|2049|3621|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|Metrónídazól||2049||2049|3621 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2632|4412|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2632||2632|4412 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5084|7740|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5084||5084|7740 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|Cítalópram||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|Cítalópram||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|Cítalópram||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|Cítalópram||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1269|2562|lyfalmen|V0923|2562|00|28|0|28|Actavis Group hf|Actavis hf|Cítalópram||1269||1269|2562 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1670 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|45583|58618|lyfsjukr|||00|5|0|7|Vistor hf|Biovitrum AB (publ)|Anakinra||45583||45583|58618 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5|Actavis Group hf|Actavis hf|Dextrómetorfan||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|175488|220350|lyfsjukr|||00|19|0|28|Vistor hf|Biovitrum AB (publ)|Anakinra||175488||175488|220350 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|197405|247637|lyfsjukr|||00|5|0|20|MedFarm ehf|E. Merck AB|Sómatrópín||197405||197405|247637 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10242|14739|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10242||10242|14739 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|11611|16323|lyfsjukr|||00|1000|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||11611||11611|16323 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|21627|28793|lyfsjukr|||00|2000|0|7|Actavis Group hf|Actavis Group hf|Metrónídazól||21627||21627|28793 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9389|7685|lyfalmen|V0714|7685|0|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5044||5044|7685 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12299|10203|lyfalmen|V0715|10203|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||6899||6899|10203 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|692|1779|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||692||692|1779 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|73544|93430|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|Omalizúmab||73544||73544|93430 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5777|8271|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||5777||5777|8271 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|410|1397|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|Metrónídazól||410||410|1397 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|700|1790|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|Metrónídazól||700||700|1790 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1324|2637|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|Metrónídazól||1324||1324|2637 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1772|3245|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1772||1772|3245 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2471|4194|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2471|4194 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|10939|7300|lyfalmen|V0437|6998|00|90|0|90|Vistor hf|Yamanouchi Europe|Tamsúlósín||4760||4760|7300 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|||10|30|0|4|Actavis Group hf|Actavis hf|Díkloxacillín||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|Díkloxacillín||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis hf|Díkloxacillín||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|24893|33177|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||24893||24893|33177 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|45089|58321|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||45089||45089|58321 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|2974|4876|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2974||2974|4876 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Napp|Joð/pólývídón||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1201|2470|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1201||1201|2470 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|62171|79588|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|Góserelín||62171||62171|79588 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|41020|53255|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|Metýlamínólevúlínat||41020||41020|53255 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1585|2991|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1585||1585|2991 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|31537|17381|lyfalmen|V0815|17381|00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||12206||12206|17381 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5657|8517|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|Alendrónsýra||5657||5657|8517 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|40109|52121|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||40109||40109|52121 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1092|2322|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1092||1092|2322 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|15688|21717|lyfalmen|V0718|7760|00|12|0|84|Icepharma hf|M.S.D.|Alendrónsýra||15688||15688|21717 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|6674|9897|lyfalmen|V2110|9897|00|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||6674||6674|9897 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7033|10385|lyfalmen|V0985|10385|0|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||7033||7033|10385 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4323|6707|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4323||4323|6707 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1703|3151|lyfalmen|||00|30|0|6|Icepharma hf|Servier|Glíklazíð||1703||1703|3151 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2969|4869|lyfalmen|||00|60|0|11|Icepharma hf|Servier|Glíklazíð||2969||2969|4869 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7884|11539|lyfalmen|||00|180|0|34|Icepharma hf|Servier|Glíklazíð||7884||7884|11539 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4332|6719|lyfalmen|||00|90|0|17|Icepharma hf|Servier|Glíklazíð||4332||4332|6719 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6559|9741|lyfalmen|||00|180|0|90|Icepharma hf|Servier|Estradíól||6559||6559|9741 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|2538|4285|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2538||2538|4285 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|4710|6744|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||4710||4710|6744 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|71935|91427|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||71935||71935|91427 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|36928|47843|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|Cetrorelix||36928||36928|47843 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|36928|47843|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||36928||36928|47843 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7765|11378|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7765||7765|11378 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|3360|5400|lyfalmen|V0939|5400|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3360||3360|5400 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|17630|30510|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||17630||17630|30510 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6844|10128|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6844||6844|10128 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|80202|101719|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||80202||80202|101719 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|11267|16130|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11267||11267|16130 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6037|9033|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6037||6037|9033 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3350|5386|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3350||3350|5386 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3181|5157|lyfalmen|||59|8|0|2|Icepharma hf|Roche|Meflókvín||3181||3181|5157 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|941|2117|lyfalmen|||00|1|0|1|Icepharma hf|Eli Lilly Nederland -|Olanzapín||941||941|2117 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|10964|15719|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10964||10964|15719 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|23030|30857|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||23030||23030|30857 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3923|6164|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan||3923||3923|6164 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7380|10855|lyfalmen|V1039|10655|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7380||7380|10855 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10068|13023|lyfalmen|V1110|10436|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan||8977||8977|13023 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|14993|20851|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14993||14993|20851 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5002|7628|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan||5002||5002|7628 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|13683|18359|lyfalmen|V1111|14728|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan||12991||12991|18359 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|90826|114946|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||90826||90826|114946 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6164|9205|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||6164||6164|9205 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|34148|44382|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||34148||34148|44382 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|131997|166204|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||131997||131997|166204 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|5980|8956|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||5980||5980|8956 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|181780|228184|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||181780||181780|228184 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|92052|116472|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||92052||92052|116472 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|972|2159|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||972||972|2159 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9079|13161|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9079||9079|13161 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|39411|50934|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||39411||39411|50934 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|67760|86229|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||67760||67760|86229 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2566|4323|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2566||2566|4323 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9399|18075|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||9399||9399|18075 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9979|14382|lyfalmen|V0391|14120|00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9979||9979|14382 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|14815|20630|lyfalmen|V2001|20260|00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14815||14815|20630 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|37371|48712|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||37371||37371|48712 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|16556|22797|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||16556||16556|22797 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|15595|21601|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan||15595||15595|21601 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4028|6307|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||4028||4028|6307 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|777|1895|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||777||777|1895 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|29935|39454|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|Sevelamer||29935||29935|39454 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|25802|49320|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||25802||25802|49320 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12814|18138|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||12814||12814|18138 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1941|3474|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1941||1941|3474 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6035|9030|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||6035||6035|9030 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19203|26093|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||19203||19203|26093 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|6278|9360|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||6278||6278|9360 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|8011|11712|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||8011||8011|11712 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|28040|37095|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||28040||28040|37095 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|159785|200800|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||159785||159785|200800 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|282253|353272|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||282253||282253|353272 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2248|3891|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2248||2248|3891 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2821|4669|lyfalmen|||00|3|0|30|Vistor hf|Allergan|Bimatóprost||2821||2821|4669 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|159328|200231|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||159328||159328|200231 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|245208|307151|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||245208||245208|307151 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|213183|267280|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||213183||213183|267280 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|139107|175056|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||139107||139107|175056 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|350461|438191|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||350461||350461|438191 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3775|5963|lyfalmen|V0988|5860|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tímólól í blöndum||3775||3775|5963 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|7598|10878|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||7598||7598|10878 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|128714|162116|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||128714||128714|162116 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|27439|36029|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Sevóflúran||27439||27439|36029 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer Animal Health GmbH||||||3632 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7338|10798|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||7338||7338|10798 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5286|8014|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5286||5286|8014 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3215|5203|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan||3215||3215|5203 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5286|8014|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5286||5286|8014 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|9701|13889|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|Paracetamól||9701||9701|13889 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22925|30727|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||22925||22925|30727 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|10302|14821|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|Mometasón||10302||10302|14821 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10185|14662|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan||10185||10185|14662 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2697|3861|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2697||2697|3861 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2449|4164|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|Candesartan||2449||2449|4164 007657|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|1|hgl||QH02AB06|01.05.1998|31.03.2009|R|A|5|0|0|0|0|INI|1|0|0|100|DKK|1773|3499|vetalmen|||58|50|0|0|Icepharma hf|Intervet International B.V.|||1773||1773|3499 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8169|11926|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||8169||8169|11926 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|24808|33071|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||24808||24808|33071 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4338|6727|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4338||4338|6727 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0|Icepharma hf|Baxter|||||| 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2433|4142|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2433||2433|4142 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1374|2705|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Ólópatadín||1374||1374|2705 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|169859|213342|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||169859||169859|213342 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23724|31404|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|Nituroxíð||23724||23724|31404 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|42800|55154|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||42800||42800|55154 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|706|1798|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformín||706||706|1798 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3778|5967|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3778||3778|5967 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|25855|34057|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||25855||25855|34057 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|32320|42106|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||32320||32320|42106 008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|378|1353|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||378||378|1353 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|7187|10593|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|Rizatriptan||7187||7187|10593 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|98602|124627|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|Peginterferón alfa 2b||98602||98602|124627 008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1198|2466|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1198||1198|2466 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|198230|248664|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|Peginterferón alfa 2b||198230||198230|248664 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|143748|180834|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|Peginterferón alfa 2b||143748||143748|180834 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|211590|265297|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|Peginterferón alfa 2b||211590||211590|265297 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|247010|309395|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|Peginterferón alfa 2b||247010||247010|309395 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2167|3781|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2167||2167|3781 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1238|2520|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1238||1238|2520 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|287|1230|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||287||287|1230 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|34049|44259|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||34049||34049|44259 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|26587|34968|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||26587||26587|34968 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|471|1480|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||471||471|1480 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|33319|43350|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||33319||33319|43350 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8301|12105|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|Candesartan||8301||8301|12105 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1255|2543|lyfalmen|V0733|2543|00|20|0|7|Actavis Group hf|Actavis hf|Tramadól||1255||1255|2543 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2631|4411|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Candesartan||2631||2631|4411 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1405|2747|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1405||1405|2747 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|8231|12010|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Candesartan||8231||8231|12010 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4912|7506|lyfalmen|V0734|7506|00|100|0|33|Actavis Group hf|Actavis hf|Tramadól||4912||4912|7506 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|7538|11070|lyfalmen|V0736|11070|00|100|0|50|Actavis Group hf|Actavis hf|Tramadól||7538||7538|11070 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|9925|14309|lyfalmen|V0738|14309|00|100|0|67|Actavis Group hf|Actavis hf|Tramadól||9925||9925|14309 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|220610|276527|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|Thýrótrópín||220610||220610|276527 008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|378|1353|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||378||378|1353 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|830|1967|lyfalmen|V0431|1967|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||830||830|1967 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|701|1792|lyfalmen|V0430|1792|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||701||701|1792 008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1198|2466|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1198||1198|2466 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5297|9167|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||5297||5297|9167 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|11631|22326|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||11631||11631|22326 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4879|7461|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4879||4879|7461 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3081|5021|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3081||3081|5021 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|140111|176306|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||140111||140111|176306 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|146051|183701|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||146051||146051|183701 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2713|4695|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2713||2713|4695 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3281|5293|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3281||3281|5293 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3215|5203|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3215||3215|5203 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2439|4150|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2439||2439|4150 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6446|9588|lyfalmen|V1350|9414|00|4|0|8|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6446|9588 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|950|2130|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||950||950|2130 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12699|17995|lyfalmen|V1351|17678|00|8|0|16|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12699|17995 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5535|8352|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5535||5535|8352 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|17182|23577|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||17182||17182|23577 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|7832|11469|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|Parekoxíb||7832||7832|11469 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|14867|20694|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|Parekoxíb||14867||14867|20694 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|64965|82749|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||64965||64965|82749 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0|Icepharma hf|Fresenius Kabi||||||1721 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5919|8873|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||5919||5919|8873 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1451|2809|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|Estradíól||1451||1451|2809 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1560|2957|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Estradíól||1560||1560|2957 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1838|3335|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|Estradíól||1838||1838|3335 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2115|3711|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|Estradíól||2115||2115|3711 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|259504|324950|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||259504||259504|324950 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6070|9078|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6070||6070|9078 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|10207|14692|lyfalmen|||00|55|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10207||10207|14692 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|74961|95194|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||74961||74961|95194 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10229|14722|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||10229||10229|14722 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|44041|56699|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|Epóetín||44041||44041|56699 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|897|2058|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||897||897|2058 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7012|10356|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||7012||7012|10356 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6884|10182|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||6884||6884|10182 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8158|11911|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8158||8158|11911 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|585|1634|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|Mirtazapín||585||585|1634 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7427|10919|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7427||7427|10919 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|8188|11952|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||8188||8188|11952 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6299|9388|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||6299||6299|9388 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2485|4213|lyfalmen|V1151|3006|00|30|0|15|Vistor hf|N.V. Organon|Mirtazapín||2485||2485|4213 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4409|6824|lyfalmen|V1152|4359|00|30|0|30|Vistor hf|N.V. Organon|Mirtazapín||4409||4409|6824 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|9417|13620|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|Mirtazapín||9417||9417|13620 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|181460|227785|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||181460||181460|227785 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|4823|7385|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|Follitrópín alfa||4823||4823|7385 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1284|2583|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||1284||1284|2583 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|49548|63872|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|Follitrópín alfa||49548||49548|63872 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|29731|39200|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||29731||29731|39200 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|258754|324016|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|Valgancíklóvír||258754||258754|324016 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|447276|558726|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||447276||447276|558726 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|172861|217079|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||172861||172861|217079 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|8736|12508|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|Ertapenem||8736||8736|12508 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|13687|19225|lyfalmen|V1153|13361|00|96|0|96|Vistor hf|N.V. Organon|Mirtazapín||13687||13687|19225 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|20735|28000|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|Mirtazapín||20735||20735|28000 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|9153|13261|lyfalmen|V1369|13261|00|30|0|15|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||9153||9153|13261 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|14950|20798|lyfalmen|||00|50|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||14950||14950|20798 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|24728|32971|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||24728||24728|32971 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|4141|6460|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4141||4141|6460 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|9533|13777|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||9533||9533|13777 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|13378|18841|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13378||13378|18841 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|78942|150544|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||78942||78942|150544 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|6745|9994|lyfalmen|||00|60|0|32|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6745||6745|9994 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|12985|18034|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|Elektrólýtar||12985||12985|18034 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8910|12757|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Amínósýrur||8910||8910|12757 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1419|2766|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|Levófloxacín||1419||1419|2766 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5224|7930|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||5224||5224|7930 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6879|9849|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Kolvetni||6879||6879|9849 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12615|17573|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Kolvetni||12615||12615|17573 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4801|6874|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||4801||4801|6874 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2751|3939|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||2751||2751|3939 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|7845|11486|lyfalmen|||00|9|0|90|Vistor hf|Allergan|Bimatóprost||7845||7845|11486 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|12615|17573|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Elektrólýtar||12615||12615|17573 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6925|9915|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Elektrólýtar||6925||6925|9915 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4616|6609|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||4616||4616|6609 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|13549|19053|lyfalmen|V1080|19053|00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||13549||13549|19053 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2562|3668|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2562||2562|3668 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|456953|570774|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||456953||456953|570774 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|427808|534488|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||427808||427808|534488 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|668478|834123|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||668478||668478|834123 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|889673|1109510|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||889673||889673|1109510 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1358|2672|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|Ómeprazól||1350||1350|2672 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6037|7550|lyfalmen|V2171|7550|10|100|0|100|Actavis Group hf|Actavis hf|Ómeprazól||4944||4944|7550 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3384|4259|lyfalmen|V2170|4259|10|56|0|56|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4259 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|50064|64197|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|Bleómýcín||50064||50064|64197 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2880|4123|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|Kloxacillín||2880||2880|4123 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|3031|4954|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|Lansóprazól||3031||3031|4954 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|23709|31703|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23709||23709|31703 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|23709|31703|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23709||23709|31703 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39678|51584|lyfalmen|V1702|51584|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||39678||39678|51584 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39678|51584|lyfalmen|V1703|51584|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||39678||39678|51584 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|18447|25151|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|Búdesóníð||18447||18447|25151 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6295|9383|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Etoríkoxíb||6295||6295|9383 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6295|9383|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|Etoríkoxíb||6295||6295|9383 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|21700|29201|lyfalmen|V2172|29201|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||21700||21700|29201 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|Lósartan||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|13144|18549|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||13144||13144|18549 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|5469|lyfalmen|V0197|5469|00|98|0|98|Actavis Group hf|Actavis hf|Lósartan||3411||3411|5469 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|8275|12070|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8275||8275|12070 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|12433|17664|lyfalmen|||00|12|0|6|Vistor hf|Bayer AG-|Vardenafíl||12433||12433|17664 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6840|10123|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6840||6840|10123 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|8036|11506|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|Mannitól||8036||8036|11506 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2580|3694|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||2580||2580|3694 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|6295|9383|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|Etoríkoxíb||6295||6295|9383 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8936|12967|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|Metýlfenídat||8936||8936|12967 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1707|3368|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1707||1707|3368 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|5161|7389|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||5161||5161|7389 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1414|2759|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1414||1414|2759 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|113501|143176|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|Ribavirin||113501||113501|143176 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|11013|15786|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||11013||11013|15786 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2003|3559|lyfalmen|V0935|3559|00|28|0|56|Actavis Group hf|Actavis hf|Sertralín||2003||2003|3559 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|7008|10351|lyfalmen|V0937|10351|00|98|0|196|Actavis Group hf|Actavis hf|Sertralín||7008||7008|10351 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|4223|6046|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||4223||4223|6046 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3835|5491|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3835||3835|5491 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|þpakki||N06DX01|01.06.2009||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8543|12434|lyfalmen|V1369|12377|00|28|0|14|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||8543|12434 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4776|7322|lyfalmen|||00|28|0|37|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||4776||4776|7322 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|16439|22652|lyfalmen|||00|98|0|131|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||16439||16439|22652 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|48218|61899|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|Efavirenz||48218||48218|61899 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|11468|16403|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||11468||11468|16403 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1335|2652|lyfalmen|||00|20|0|36|Vistor hf|Meda AB|Azelastínum||1335||1335|2652 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6424|9558|lyfalmen|||00|4|0|4|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6424||6424|9558 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5993|10371|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||5993||5993|10371 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|871|2022|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |Glímepíríð||871||871|2022 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|10590|15212|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|Metýlfenídat||10590||10590|15212 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|28166|48743|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||28166||28166|48743 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|529094|660590|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Díbótermín alfa||529094||529094|660590 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4433|6856|lyfalmen|||00|4|0|2|Vistor hf|Bayer AG-|Vardenafíl||4433||4433|6856 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4905|7497|lyfalmen|||00|4|0|4|Vistor hf|Bayer AG-|Vardenafíl||4905||4905|7497 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|14450|20175|lyfalmen|||00|12|0|12|Vistor hf|Bayer AG-|Vardenafíl||14450||14450|20175 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|6081|9093|lyfalmen|||00|4|0|8|Vistor hf|Bayer AG-|Vardenafíl||6081||6081|9093 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|17583|24076|lyfalmen|||00|12|0|24|Vistor hf|Bayer AG-|Vardenafíl||17583||17583|24076 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|4240|6594|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4240||4240|6594 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6555|9736|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|Testósterón||6555||6555|9736 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6597|9793|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6597||6597|9793 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7234|13951|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7234||7234|13951 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|10765|15449|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||10765||10765|15449 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1876|3702|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1876||1876|3702 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|1338|2656|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|Lansóprazól||1338||1338|2656 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|23724|31404|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|Nituroxíð||23724||23724|31404 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|9391|13446|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||9391||9391|13446 013259|B02BD0402|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|34976|45413|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||34976||34976|45413 013270|B02BD0402|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|69956|88963|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||69956||69956|88963 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4751|9221|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4751||4751|9221 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|11418|21921|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||11418||11418|21921 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1198|2364|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1198||1198|2364 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|192636|241699|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||192636||192636|241699 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|32106|41839|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||32106||32106|41839 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|128423|161754|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||128423||128423|161754 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|62540|79730|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||62540||62540|79730 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|20107|27218|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Ezetimíb||20107||20107|27218 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|198466|248958|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||198466||198466|248958 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf|Blöndur|||||1367 013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002|30.04.2009|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|6327|9426|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||6327||6327|9426 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1343|2663|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1343||1343|2663 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|489|1504|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||489||489|1504 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|48942|62800|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||48942||48942|62800 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|5022|7655|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5022||5022|7655 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|15170|21072|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15170||15170|21072 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2489 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7437|10933|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||7437||7437|10933 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5777|8680|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||5777||5777|8680 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2830|4681|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2830||2830|4681 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|4957|7567|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||4957||4957|7567 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|221891|278122|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||221891||221891|278122 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|416412|520300|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||416412||416412|520300 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2806|4648|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2806||2806|4648 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|15354|20983|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|Esómeprazól||15354||15354|20983 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|25085|33416|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|Levetíracetam||25085||25085|33416 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|61209|78390|lyfalmen|||AC|3|0|38|Icepharma hf|Eli Lilly Nederland -|Teriparatíð||61209||61209|78390 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|38439|49724|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||38439||38439|49724 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1355|2679|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1355||1355|2679 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23678|31347|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||23678||23678|31347 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26073|34328|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|Blöndur||26073||26073|34328 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34122|44349|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||34122||34122|44349 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|23678|31347|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||23678||23678|31347 014435|QM01AE03  |Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|A|3|0|0|0|0|VET|0|0|0|100|XEU|2452|4839|vetalmen|||00|45|0|0|Dýraheilsa ehf|Vetcare Ltd.|||||2452|4839 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|16306|22486|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||16306||16306|22486 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|88488|112035|lyfsjukr|||0|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|||||88488|112035 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|6094|11779|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||6094||6094|11779 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|312987|391536|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|Enfúvirtíð||312987||312987|391536 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2578|4339|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |Oxýcódon||2578||2578|4339 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4576|7050|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|Candesartan||4576||4576|7050 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|15487|21466|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|Candesartan||15487||15487|21466 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|80678|102312|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|Fílgrastím||80678||80678|102312 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|124892|157358|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|Fílgrastím||124892||124892|157358 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|20650|27894|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|Everolímus||20650||20650|27894 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|62312|79763|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|Everolímus||62312||62312|79763 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|41477|53824|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|Everolímus||41477||41477|53824 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|680|1763|lyfalmen|||00|10|0|18|Vistor hf|Meda AB|Azelastínum||680||680|1763 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Mirtazapín||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|9201|13327|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||9201||9201|13327 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Mirtazapín||2563||2563|4318 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4586|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4586 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1166|2423|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|Estradíól||1166||1166|2423 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|11329|16214|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||11329||11329|16214 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|369771|462232|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||369771||369771|462232 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|98283|124230|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||98283||98283|124230 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6557|9739|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6557||6557|9739 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14451|20176|lyfalmen|V1732|20175|00|100|0|11|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14451||14451|20176 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6557|9739|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6557||6557|9739 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|15621|21633|lyfalmen|V1731|21633|00|100|0|33|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15621||15621|21633 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|35815|46775|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||35815||35815|46775 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85542|108367|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||85542||85542|108367 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85542|108367|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||85542||85542|108367 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85542|108367|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||85542||85542|108367 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6557|9739|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6557||6557|9739 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|14298|19986|lyfalmen|V1730|19986|00|100|0|22|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14298||14298|19986 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|85542|108367|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||85542||85542|108367 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|29703|39165|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||29703||29703|39165 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|51659|66500|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||51659||51659|66500 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1025|2231|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Cýklópentólat||1025||1025|2231 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3410|5901|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3410||3410|5901 015833|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|4028|5767|lyfsjukr|||00|750|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||4028|5767 015844|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|7705|11032|lyfsjukr|||00|1500|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||7705|11032 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4792|8293|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||4792||4792|8293 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3042|5264|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3042||3042|5264 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3814|6600|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||3814||3814|6600 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4860|7436|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4860||4860|7436 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4273|7395|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||4273||4273|7395 015912|D11AX1401|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AX14|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2149|3757|lyfalmen|||0|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||||2149|3757 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2413|4115|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||2413||2413|4115 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1563|2961|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|Morfín||1563||1563|2961 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3410|5901|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3410||3410|5901 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|100|GBP|1504|2881|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1504||1504|2881 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|16575|22821|lyfalmen|||00|90|0|180|Icepharma hf|Servier|Perindópríl||16575||16575|22821 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|5218|7921|lyfalmen|||00|6|0|6|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||5218||5218|7921 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|5575|8406|lyfalmen|||00|30|0|60|Icepharma hf|Servier|Perindópríl||5575||5575|8406 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|7387|10865|lyfalmen|||00|9|0|9|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||7387||7387|10865 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13085|18476|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||13085||13085|18476 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1162|2417|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|Petidín||1162||1162|2417 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|19605|26593|lyfalmen|||00|100|0|200|Vistor hf|AstraZeneca A/S DK|||19605||19605|26593 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1231|2511|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|Petidín||1231||1231|2511 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|2694|4496|lyfalmen|||00|3|0|3|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||2694||2694|4496 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8097|11828|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||8097||8097|11828 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|7826|11461|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|Risperídón||7826||7826|11461 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4529|6986|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||4529||4529|6986 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3517|5613|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3517||3517|5613 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7471|10979|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7471||7471|10979 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|4867|7445|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|Chóríógónadótrópín alfa||4867||4867|7445 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11374|16275|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||11374||11374|16275 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2362|4046|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2362||2362|4046 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|15776|21826|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15776||15776|21826 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11944|17049|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|Ísradipín||11944||11944|17049 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4408|6822|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|Risperídón||4408||4408|6822 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|4963|7106|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||4963||4963|7106 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|6282|8994|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||6282||6282|8994 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|18245|24583|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||18245||18245|24583 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|150436|189160|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||150436||150436|189160 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|9124|13063|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||9124||9124|13063 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2799|4639|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2799||2799|4639 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8436|12078|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||8436||8436|12078 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|28599|37473|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||28599||28599|37473 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|240171|300880|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||240171||240171|300880 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|84231|106735|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||84231||84231|106735 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|19939|27009|lyfalmen|V1701|26512|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19939||19939|27009 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7400 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|39877|51832|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||39877||39877|51832 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2233|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|257104|321962|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|Epóetín||257104||257104|321962 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|224768|281704|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||224768||224768|281704 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2936|4825|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|Metformín||2936||2936|4825 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8791|12770|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8791||8791|12770 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|74923|95147|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||74923||74923|95147 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3991|6256|lyfalmen|V0789|5300|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3991||3991|6256 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|7276|10714|lyfalmen|V0713|10714|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||7276||7276|10714 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|69047|88148|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|Cinacalcet||69047||69047|88148 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|102061|129251|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|Cinacalcet||102061||102061|129251 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|33213|43535|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|Cinacalcet||33213||33213|43535 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|55599|71406|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|Follitrópín alfa||55599||55599|71406 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|21267|28662|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|Follitrópín alfa||21267||21267|28662 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|31898|41898|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||31898||31898|41898 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|2481|4207|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|Lansóprazól||2481||2481|4207 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|4815|7375|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|Lansóprazól||4815||4815|7375 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|9376|13564|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|Lansóprazól||9376||9376|13564 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|9446|13659|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|Lansóprazól||9446||9446|13659 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|43167|55610|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||43167||43167|55610 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|16548|22787|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|Lansóprazól||16548||16548|22787 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3724|5894|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |Búprenorfín||3724||3724|5894 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|20172|38596|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||20172||20172|38596 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34901|45319|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|Blöndur||34901||34901|45319 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1643|3070|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Medroxýprógesterón||1643||1643|3070 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1662|3096|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1662||1662|3096 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|309153|386763|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|Cýtarabín||309153||309153|386763 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7442|10940|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|Diltíazem||7442||7442|10940 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|171116|214907|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||171116||171116|214907 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|48740|62549|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||48740||48740|62549 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36073|46778|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|Blöndur||36073||36073|46778 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1547|2940|lyfalmen|V0221|2940|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1547||1547|2940 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|146963|184836|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||146963||146963|184836 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|54394|69906|lyfalmen|||00|28|0|0|Icepharma hf|Roche|||54394||54394|69906 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|162356|204318|lyfalmen|||00|84|0|0|Icepharma hf|Roche|||162356||162356|204318 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6592|9786|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |Búprenorfín||6592||6592|9786 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5440|8223|lyfalmen|V0714|7685|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Gabapentín||5440||5440|8223 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|12311|17512|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |Búprenorfín||12311||12311|17512 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2897|4772|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2897||2897|4772 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|12255|17125|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|Aprepitant||12255||12255|17125 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|3031|4954|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|Prednisón||3031||3031|4954 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7768|11382|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |Betahistín||7768||7768|11382 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|7199|13884|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7199||7199|13884 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|37546|48930|lyfalmen|V1371|48930|00|84|0|84|Vistor hf|Janssen-Cilag AB|Galantamín||37546||37546|48930 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|11664|16669|lyfalmen|V1370|16669|00|28|0|14|Vistor hf|Janssen-Cilag AB|Galantamín||11664||11664|16669 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12047|17183|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||12047||12047|17183 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|46911|60589|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|Galantamín||46911||46911|60589 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12047|17183|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||12047||12047|17183 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2704|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||1373||1373|2704 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|6333|9435|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||6333||6333|9435 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2904|4781|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|||2904||2904|4781 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|4289|6661|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|||4289||4289|6661 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|64210|81809|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||64210||64210|81809 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|13432|18908|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|||13432||13432|18908 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|9434|13643|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|||9434||9434|13643 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3426|5490|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3426||3426|5490 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3741|5917|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3741||3741|5917 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|11080|15876|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|||11080||11080|15876 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17224|23311|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||17224||17224|23311 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|85166|107899|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||85166||85166|107899 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3607|5735|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3607||3607|5735 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|34691|45058|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||34691||34691|45058 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8887|12900|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|Sólífenacín||8887||8887|12900 018617|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005|31.03.2009|R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|87947|111362|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||87947||87947|111362 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|14702|20171|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|Ceftríaxón||14702||14702|20171 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1569|2970|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Valsartan||1569||1569|2970 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|21776|29296|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|Sólífenacín||21776||21776|29296 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3139|5100|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|Valsartan||3139||3139|5100 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1193|2459|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |Prednisólón||1193||1193|2459 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|7011|10355|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Sólífenacín||7011||7011|10355 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|17730|24259|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Sólífenacín||17730||17730|24259 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|40164|52189|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||40164||40164|52189 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|144244|181451|lyfsjukr|||00|28|0|0|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||||144244|181451 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|51527|65801|lyfalmen|V0375|41080|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||51097||51097|65801 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|55933|71016|lyfalmen|V0376|45840|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||55286||55286|71016 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|15688|21717|lyfalmen|V0718|7760|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|Alendrónsýra||15688||15688|21717 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3346|5381|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3346||3346|5381 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|10351|14887|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||10351||10351|14887 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|59865|76399|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Fosamprenavír||59865||59865|76399 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|640|1709|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||640||640|1709 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1224|2415|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1224||1224|2415 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|13887|19474|lyfalmen|V1052|14628|00|5|0|62|Vistor hf|Janssen-Cilag AB|Fentanýl||13887||13887|19474 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15797|21852|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15797||15797|21852 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15797|21852|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15797||15797|21852 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15486|20728|lyfalmen|V1372|20727|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14894||14894|20728 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|9008|13065|lyfalmen|V1051|10694|00|5|0|42|Vistor hf|Janssen-Cilag AB|Fentanýl||9008||9008|13065 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|7899|11560|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7899||7899|11560 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4868|7446|lyfalmen|V1050|5958|00|5|0|21|Vistor hf|Janssen-Cilag AB|Fentanýl||4868||4868|7446 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|15567|21566|lyfalmen|V1053|17391|00|5|0|83|Vistor hf|Janssen-Cilag AB|Fentanýl||15567||15567|21566 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|61154|78004|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||61154||61154|78004 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|797582|994857|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||797582||797582|994857 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7336|10796|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7336||7336|10796 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|63813|81315|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||63813||63813|81315 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|7336|10796|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||7336||7336|10796 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|18052|24660|lyfalmen|||00|140|0|0|Icepharma hf|Eli Lilly Nederland -|||18052||18052|24660 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|643|1713|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||643||643|1713 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3924|6165|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||3924||3924|6165 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|9804|14145|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||9804||9804|14145 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5593|8430|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||5593||5593|8430 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|18673|25433|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||18673||18673|25433 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3924|6165|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||3924||3924|6165 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|13702|19244|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||13702||13702|19244 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6496|9301|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6496||6496|9301 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5593|8430|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5593||5593|8430 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|18673|25433|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||18673||18673|25433 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|672|1752|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||672||672|1752 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|32359|42154|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||32359||32359|42154 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|233493|292566|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||233493||233493|292566 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|986|2178|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||986||986|2178 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|235289|294802|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Pemetrexed||235289||235289|294802 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13050|18432|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13050||13050|18432 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13050|18432|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13050||13050|18432 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|59730|76549|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|Follitrópín beta||59730||59730|76549 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13050|18432|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13050||13050|18432 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13050|18432|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13050||13050|18432 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|13050|18432|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13050||13050|18432 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|843168|1051612|lyfsjukr|||02|6|0|9|Vistor hf|Biovitrum AB (publ)|Palifermín||843168||843168|1051612 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|395|1376|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||395||395|1376 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|67838|86326|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||67838||67838|86326 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1477|2845|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1477||1477|2845 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Ferrósúlfat||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020180|C03CC0101|Edecrin|sts|0| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|26861|35309|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||26861||26861|35309 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4783|7331|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4783||4783|7331 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|26450|35115|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||26450||26450|35115 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2605|4375|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2605||2605|4375 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|856|2002|lyfalmen|||00|7|0|3|Icepharma hf|Wyeth AB|Venlafaxín||856||856|2002 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|10515|15110|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Tamsúlósín||10515||10515|15110 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|57003|73154|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||57003||57003|73154 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|4161|6487|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4161||4161|6487 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|100|DKK|3892|6122|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3892||3892|6122 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12029|17161|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12029||12029|17161 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|26430|35090|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||26430||26430|35090 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|778|1896|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||778||778|1896 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7424|10915|lyfalmen|||00|28|0|28|Icepharma hf|Servier|Strontíum ranelat||7424||7424|10915 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2269|3920|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2269||2269|3920 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4565|6241|lyfalmen|V0709|6241|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||3980||3980|6241 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|6654|9734|lyfalmen|V0710|9733|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||6554||6554|9734 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|13263|16898|lyfalmen|V0711|16898|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||11833||11833|16898 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3385|5434|lyfalmen|V0939|5400|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Escítalópram||3385||3385|5434 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|21778|29299|lyfalmen|||00|84|0|84|Icepharma hf|Servier|Strontíum ranelat||21778||21778|29299 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki||G03CA03|01.07.2004|31.05.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2051|3624|lyfalmen|||5|15|0|15|D.A.C. ehf|D.A.C. ehf|Estradíól||2051||2051|3624 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK||5327|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|Gabapentín||3306||3306|5327 020700|L04AA2101|Raptiva|sts|100|mg/ml|125|mg|4|hgl|+ leysir|L04AA21|01.05.2005|31.03.2009|R|K|4|0|1|0|1|SEE|0|0|0|100|SEK|149341|187797|lyfsjukr|||00|500|0|50|Gróco ehf|Serono Europe|||149341||149341|187797 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||| 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004|31.05.2009|R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7715|11310|lyfalmen|||0|120|0|30|D.A.C. ehf|D.A.C. ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7715||7715|11310 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2384|4126|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2384||2384|4126 020774|L04AB0101|Enbrel|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|215831|270577|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||215831||215831|270577 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996||R|A|3|0|0|B|0|WLN|0|1|0|100|USD|2554|4306|lyfalmen|||00|28|0|10|Icepharma hf|Wyeth Lederle Nordiska|Venlafaxín||||2554|4306 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2955|4850|lyfalmen|V0429|4850|00|3|0|5|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2955||2955|4850 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006|31.05.2009|R|K|3|0|0|E|0|BIP|0|0|0|100|SEK|5510|8318|lyfalmen|||00|100|0|0|Vistor hf|BioPhausia AB|Acetýlcýstein||5510||5510|8318 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6472|9623|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|Montelúkast||6472||6472|9623 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2269|3920|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|Adapalen||2269||2269|3920 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|714|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3699|5860|lyfalmen|V0988|5860|06|2|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||3699||3699|5860 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|9686|12310|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|Quetíapín||8452||8452|12310 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004|31.05.2009|R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|11974|15545|lyfalmen|||00|60|0|20|D.A.C. ehf|D.A.C. ehf|Tópíramat||10836||10836|15545 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2233|lyfalmen|V0466|2233|00|12|0|12|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1026||1026|2233 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1436|lyfalmen|V0609|1424|00|30|0|15|Actavis Group hf|Actavis hf|Díklófenak||439||439|1436 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1091|2321|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Dexpantenól||1091||1091|2321 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004|31.05.2009|R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1705|3154|lyfalmen|||23|200|0|50|D.A.C. ehf|D.A.C. ehf|Terbútalín||1705||1705|3154 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|4162|3590|lyfalmen|V0931|2428|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Sertralín||2026||2026|3590 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|6494|5452|lyfalmen|V0935|3559|00|28|0|56|D.A.C. ehf|D.A.C. ehf|Sertralín||3398||3398|5452 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|16332|22518|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|Testósterón||16332||16332|22518 021278|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2009||R|K|3|0|0|*|0|DAC|0|0|0|100|DKK|2923|4807|lyfalmen|V1989|4807|0|2|0|25|D.A.C. ehf|D.A.C. ehf|Latanóprost||||2923|4807 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|7570|11113|lyfalmen|V0985|10385|0|30|0|30|D.A.C. ehf|D.A.C. ehf|Tíótrópíumbrómíð||7570||7570|11113 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|8960|13000|lyfalmen|V0993|13000|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||8960|13000 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18477|25189|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|Montelúkast||18477||18477|25189 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|6845|10129|lyfalmen|V0992|10129|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||6845|10129 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5275|7999|lyfalmen|V0085|7999|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5275||5275|7999 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|XEU|19423|22125|lyfalmen|V0560|22125|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Bíkalútamíð||16016||16016|22125 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004|31.05.2009|R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1377|2709|lyfalmen|||24|120|0|38|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1377||1377|2709 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|13030|18407|lyfalmen|V0729|16976|0|100|0|20|D.A.C. ehf|D.A.C. ehf|Entakapón||13030||13030|18407 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6|Vistor hf|Boehringer Ingelheim|Bisakódýl||||| 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|11887|16972|lyfalmen|V0728|16972|00|84|0|28|D.A.C. ehf|D.A.C. ehf|Rópíníról||11887||11887|16972 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|24226|32346|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|Montelúkast||24226||24226|32346 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2985|4274|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|Própófól||2985||2985|4274 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|3057|4989|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3057||3057|4989 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|5004|7631|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|Búdesóníð||5004||5004|7631 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4983|7603|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4983||4983|7603 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|15745|21788|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|Desmópressín||15745||15745|21788 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12815|18140|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||12815||12815|18140 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|9285|13441|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||9285||9285|13441 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|29913|39109|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|Própófól||29913||29913|39109 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|26803|35555|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|Desmópressín||26803||26803|35555 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|39092|50537|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||39092||39092|50537 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26084|34660|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||26084||26084|34660 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|4028|6307|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||4028||4028|6307 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|18397|24772|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||18397||18397|24772 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|4918|7041|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tranexamsýra||4918||4918|7041 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||20883||20883|28184 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4108|6415|lyfalmen|V1951|6415|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4108||4108|6415 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|5275|7999|lyfalmen|V0085|7999|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||5275||5275|7999 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|27410|35993|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||27410||27410|35993 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5677|8544|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||5677||5677|8544 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|19564|26542|lyfalmen|||00|98|0|98|Icepharma hf|Eli Lilly Nederland -|||19564||19564|26542 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||20883||20883|28184 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|97326|123038|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||97326||97326|123038 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|762|1504|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||762||762|1504 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45|Actavis Group hf|Actavis Group hf|Natríumflúoríð||||| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|31280|41129|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||31280||31280|41129 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|36569|47713|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||36569||36569|47713 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|38654|50309|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||38654||38654|50309 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|336632|420974|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||336632||336632|420974 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|347292|434246|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||347292||347292|434246 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1424|lyfalmen|V0917|1424|00|20|0|20|Actavis Group hf|Actavis hf|Paroxetín||430||430|1424 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|11004|19043|vetorma|||00|24|0|0|Vistor hf|Bayer Animal Health GmbH|||11004||11004|19043 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|25494|33925|lyfalmen|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||25494||25494|33925 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2433|4210|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2433||2433|4210 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|3126|5083|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||3126||3126|5083 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||2028 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|7296|4772|lyfalmen|V0308|3043|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||2897||2897|4772 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|11317|7090|lyfalmen|V0310|4428|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||4605||4605|7090 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2305|3989|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2305||2305|3989 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|797|1922|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||797||797|1922 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2317|3985|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2317||2317|3985 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1492|2582|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1492||1492|2582 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|5020|7653|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||5020||5020|7653 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2400|3240|lyfalmen|V0919|3240|00|100|0|100|Actavis Group hf|Actavis hf|Paroxetín||1768||1768|3240 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|2385|lyfalmen|V0918|2385|00|60|0|60|Actavis Group hf|Actavis hf|Paroxetín||1138||1138|2385 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|USD|1480|2849|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|Metótrexat||1480||1480|2849 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|4211|6555|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|Mesalazín (5-amínósalicýlsýra)||4211||4211|6555 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|14561|20313|lyfalmen|V0192|18685|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||14561||14561|20313 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|241288|302271|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||241288||241288|302271 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||2858 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|||67|30|0|10|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|||67|30|0|20|Actavis Group hf|Actavis hf|Ísótretínóín||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26084|34660|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||26084||26084|34660 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||20883||20883|28184 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4222|6570|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4222||4222|6570 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6071|9079|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|Darífenacín||6071||6071|9079 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|129027|162506|lyfsjukr|||00|30|0|0|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||129027||129027|162506 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|27606|36554|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||27606||27606|36554 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|43100|55844|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||43100||43100|55844 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|21826|29358|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||21826||21826|29358 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|6131|9160|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|Darífenacín||6131||6131|9160 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|22047|29633|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||22047||22047|29633 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|22379|29729|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|Flúmazeníl||22379||22379|29729 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|7428|10921|lyfalmen|V0715|10203|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|Gabapentín||7428||7428|10921 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|0|100|XEU|17713|24238|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|Blöndur||17713||17713|24238 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|9224|13206|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|Darbepóetín alfa||9224||9224|13206 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|36309|47072|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|Darbepóetín alfa||36309||36309|47072 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|27481|36081|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|Darbepóetín alfa||27481||27481|36081 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|65420|83315|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|Darbepóetín alfa||65420||65420|83315 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|43676|56244|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|Darbepóetín alfa||43676||43676|56244 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8808|12611|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||8808||8808|12611 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|130755|164657|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||130755||130755|164657 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|22020|29282|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||22020||22020|29282 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17961|24229|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|Darbepóetín alfa||17961||17961|24229 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|13012|18385|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13012||13012|18385 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|44041|56699|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||44041||44041|56699 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|88080|111527|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||88080||88080|111527 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|9109|13202|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||9109||9109|13202 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|209126|262229|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||209126||209126|262229 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|176161|221188|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||176161||176161|221188 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|18216|24864|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||18216||18216|24864 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|13662|19194|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13662||13662|19194 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|149629|188156|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |Tipranavír||149629||149629|188156 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|25540|33982|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||25540||25540|33982 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4434|6858|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4434||4434|6858 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3871|6094|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|Tímólól||3871||3871|6094 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|69083|87876|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|Saquínavír||69083||69083|87876 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|10236|14731|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10236||10236|14731 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|101225|127893|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|Síldenafíl||101225||101225|127893 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|4095|6397|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||4095||4095|6397 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|91998|116405|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|Tigecýklín||91998||91998|116405 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|5443|7793|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|Cefazólín||5443||5443|7793 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4203|6544|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|Fentanýl||4203||4203|6544 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|21209|28590|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||21209||21209|28590 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2198|3147|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2198||2198|3147 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|9122|13219|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||9122||9122|13219 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15949|22041|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||15949||15949|22041 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|70696|90201|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||70696||70696|90201 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26084|34660|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||26084||26084|34660 024478|V04CL0024|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8211|11983|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8211||8211|11983 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|393|1374|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|Terbútalín||393||393|1374 024482|V04CL0025|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8211|11983|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8211||8211|11983 024504|V04CL0011|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13836|19411|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13836||13836|19411 024510|V04CL0012|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13836|19411|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13836||13836|19411 024526|V04CL0014|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13859|19439|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13859||13859|19439 024532|V04CL0015|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13836|19411|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13836||13836|19411 024559|V04CL0016|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13836|19411|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13836||13836|19411 024565|V04CL0017|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14001|19616|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14001||14001|19616 024576|V04CL0018|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13836|19411|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13836||13836|19411 024583|V04CL0019|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8211|11983|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8211||8211|11983 024589|V04CL0020|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13836|19411|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13836||13836|19411 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|78161|99495|lyfalmen|||00|100|0|125|Vistor hf|Novartis Europharm Ltd|||78161||78161|99495 024600|V04CL0021|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|14001|19616|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||14001||14001|19616 024603|V04CL0009|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1686|3128|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1686||1686|3128 024622|V04CL0013|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8211|11983|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8211||8211|11983 024644|V04CL0023|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8211|11983|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8211||8211|11983 024670|V04CL0022|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|8211|11983|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8211||8211|11983 024681|V04CL0010|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1686|3128|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1686||1686|3128 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|1100|2333|lyfalmen|V0143|2267|70|30|0|30|D.A.C. ehf|D.A.C. ehf|Amíódarón||1100||1100|2333 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|6178|9224|lyfalmen|||00|4|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||6178||6178|9224 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|985|2177|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||985||985|2177 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||20883||20883|28184 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2818|4665|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2818||2818|4665 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1927|3455|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1927||1927|3455 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3666|5815|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3666||3666|5815 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||20883||20883|28184 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|959|2142|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|Cefalexín||959||959|2142 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|14811|20625|lyfalmen|||00|12|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||14811||14811|20625 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|Cefalexín||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|107417|135602|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||107417||107417|135602 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|106195|134080|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||106195||106195|134080 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|10348|19883|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||10348||10348|19883 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|19169|26050|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||19169||19169|26050 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|23315|31212|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan||23315||23315|31212 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6801|10070|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|Valsartan||6801||6801|10070 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|7232|10655|lyfalmen|V1039|10655|00|28|0|56|D.A.C. ehf|D.A.C. ehf|Escítalópram||7232||7232|10655 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|30923|40684|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|Risperídón||30923||30923|40684 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2020|3582|lyfalmen|V1090|3582|06|5|0|17|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||2020||2020|3582 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|5666|8529|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||5666||5666|8529 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|14779|20585|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||14779||14779|20585 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2894|4560|lyfalmen|V0989|4274|06|5|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||2741||2741|4560 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|16509|22739|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|Risperídón||16509||16509|22739 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|23877|31912|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|Risperídón||23877||23877|31912 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007|31.05.2009|R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3623|5757|lyfalmen|||23|200|0|100|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3623||3623|5757 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|59847|76694|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||59847||59847|76694 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6572|9409|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||6572||6572|9409 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26084|34660|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||26084||26084|34660 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|895|2055|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||895||895|2055 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3771|6526|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||3771||3771|6526 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|923|2093|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||923||923|2093 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1646|3074|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||1646||1646|3074 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8534|14769|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||8534||8534|14769 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||20883||20883|28184 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1847|3347|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Nítrófúrantóín||1847||1847|3347 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|384|1361|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|Nítrófúrantóín||384||384|1361 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2916|4798|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2916||2916|4798 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|7390|10869|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Cýpróterón||7390||7390|10869 027281|N06DA0204 |Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|31914|41918|lyfalmen|V0375|41918|00|100|0|67|Actavis Group hf|Actavis hf|Dónepezíl||||31914|41918 027305|N06DA0204 |Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|35816|46776|lyfalmen|V0376|46776|00|100|0|133|Actavis Group hf|Actavis hf|Dónepezíl||||35816|46776 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|72450|92068|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||72450|92068 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|88574|112142|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||88574|112142 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|191177|239883|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||191177|239883 027397|G02CX0102 |Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|5797|8300|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||5797|8300 027408|G02CX0102 |Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|17269|23367|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||17269|23367 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1878|3389|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||1878||1878|3389 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7513|11036|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||7513||7513|11036 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|10057|14488|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||10057||10057|14488 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|13283|18722|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||13283||13283|18722 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|952|2132|lyfalmen|V0431|1967|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||952||952|2132 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|907|2071|lyfalmen|V0430|1792|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||907||907|2071 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|132982|167430|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|Posacónazól||132982||132982|167430 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25595|34051|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25595||25595|34051 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|25595|34051|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25595||25595|34051 028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4246|6602|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4246|6602 028179|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|98|stk|1|þpakki|150/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|14760|20561|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||14760|20561 028190|C09XA5201|Rasilez HCT|filmhtfl|175|mg|28|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4246|6602|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4246|6602 028201|C09XA5201|Rasilez HCT|filmhtfl|175|mg|98|stk|1|þpakki|150/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|14760|20561|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||14760|20561 028212|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|28|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4894|7482|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4894|7482 028224|C09XA5201|Rasilez HCT|filmhtfl|312,5|mg|98|stk|1|þpakki|300/12,5 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17025|23381|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||17025|23381 028235|C09XA5201|Rasilez HCT|filmhtfl|325|mg|28|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4894|7482|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||||4894|7482 028246|C09XA5201|Rasilez HCT|filmhtfl|325|mg|98|stk|1|þpakki|300/25 mg|C09XA52|01.06.2009||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17025|23381|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||||17025|23381 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2731|4546|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2731||2731|4546 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22925|30727|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||22925||22925|30727 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8773|12746|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||8773||8773|12746 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1326|2640|lyfalmen|V0712|2640|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Baklófen||1326||1326|2640 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1889|3404|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1889||1889|3404 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3547|5654|lyfalmen|V0351|3898|10|60|0|30|Vistor hf|Ferrosan A/S|Diltíazem||3547||3547|5654 028575|N03AX0901 |Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1278|2575|lyfalmen|||00|56|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2575 028586|N03AX0901 |Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|5812|8728|lyfalmen|||00|98|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||5812|8728 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|975|2163|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat og sýkla­eyðandi lyf||975||975|2163 028598|N03AX0901 |Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|10358|14897|lyfalmen|||00|98|0|65|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||10358|14897 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|8588|16530|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||8588||8588|16530 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|970|2157|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||970||970|2157 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12823|18150|lyfalmen|||00|10|0|5|Icepharma hf|Roche as|Granisetrón||12823||12823|18150 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2223|3857|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2223||2223|3857 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1101|2334|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1101|2334 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1027|2234|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||1027||1027|2234 029287|C03DB0105 |Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|257|1189|lyfalmen|||00|28|0|14|Actavis Group hf|Actavis UK Ltd.|||||257|1189 029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|411|1398|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||411||411|1398 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7495|11011|lyfalmen|||0|7|0|0|D.A.C. ehf|D.A.C. ehf|Búdesóníð||||7495|11011 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|9033|6156|lyfalmen|||00|98|0|33|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||3917||3917|6156 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8175|9703|lyfalmen|||00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6531||6531|9703 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|12847|13108|lyfalmen|V0367|2685|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||9040||9040|13108 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|18066|24677|lyfalmen|||00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||18066||18066|24677 029517|L01BB0503 |Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|33882|44051|lyfsjukr|||00|50|0|0|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||33882|44051 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|21806|29016|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||||21806|29016 029574|L01XX1904 |Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|21842|29061|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group hf|Írinótekan||||21842|29061 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|20275|27110|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|Ritonavír||||20275|27110 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|23234|31111|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||23234||23234|31111 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|489|1504|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||489||489|1504 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1928|3457|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||1928||1928|3457 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyflausa|||00|60|0|25|Icepharma hf|Navamedic ASA|Glúkósamín||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|9981|14385|lyfalmen|V1400|14385|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Klózapín||9981||9981|14385 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3184|5161|lyfalmen|V1401|5161|00|100|0|8|Vistor hf|Novartis Healthcare A/S-|Klózapín||3184||3184|5161 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|885|2041|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Metóprólól||885||885|2041 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1291|2592|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|Metóprólól||1291||1291|2592 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|901|2063|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||901||901|2063 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3410|5468|lyfalmen|||17|10|0|25|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||3410||3410|5468 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4940|7544|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4940||4940|7544 031555|J06BA0105|Gammanorm (D.A.C.)|stl|165|mg/ml|10|ml|1|lykja||J06BA01|01.03.2009|31.03.2009|R|K|3|0|0|0|1|DAC|0|0|0|100|DKK|12741|17730|lyfsjukr|||0|10|0|0|D.A.C. ehf|D.A.C. ehf|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||||12741|17730 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2071|3651|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Ísósorbíð dínítrat||2071||2071|3651 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6786|10049|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||6786||6786|10049 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|39959|51616|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|Terlípressín||39959||39959|51616 031971|C07AA0704|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1808|3294|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Sótalól||1808||1808|3294 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|10419|14839|lyfsjukr|||0|4|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||10419|14839 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|15229|20828|lyfsjukr|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||15229|20828 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|52694|67472|lyfsjukr|||0|50|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||52694|67472 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|26578|35275|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||26578||26578|35275 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|4112|7116|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||4112||4112|7116 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|137957|173624|lyfsjukr|||0|6|0|0|Gróco ehf|Serono Nordic|Interferón beta-1a||||137957|173624 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|14623|25306|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||14623||14623|25306 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|496|1513|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|Atrópín||496||496|1513 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1328|2643|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Dexametasón||1328||1328|2643 033918|L04AC0501|Stelara|stl|45|mg/hgl|0,5|mg|1|hgl||L04AC05|01.06.2009||R|K|1|0|1|0|1|JCI|0|0|0|100|SEK|550339|687040|lyfsjukr|||AC|0|0|0|Vistor hf|Janssen-Cilag International N.V.|||||550339|687040 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2685|5286|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2685|5286 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|809|1938|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||809||809|1938 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|2113|3708|lyfalmen|||00|300|0|10|Vistor hf|Astra|Clómetíazól||2113||2113|3708 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1984|3533|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1984||1984|3533 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3403|5458|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3403||3403|5458 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9595|13738|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|Prótamín||9595||9595|13738 035099|C02CA0404 |Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|9919|14301|lyfalmen|V2120|14301|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Doxazósín||||9919|14301 035155|N03AX1403 |Keppra (D.A.C.)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2009||R|A|3|0|1|E|0|DAC|0|0|0|100|DKK|20455|27651|lyfalmen|V1710|26033|00|100|0|25|D.A.C. ehf|D.A.C. ehf|Levetíracetam||||20455|27651 035177|N03AX1203 |Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6481|9635|lyfalmen|V0714|7685|10|100|0|17|D.A.C. ehf|D.A.C. ehf|Gabapentín||||6481|9635 035200|N03AX1203 |Neurontin (D.A.C.)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|18087|24703|lyfalmen|V2160|24703|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Gabapentín||||18087|24703 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|18798|25588|lyfalmen|||10|300|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||18798||18798|25588 035222|N06DA0403 |Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|11958|17068|lyfalmen|V1370|16669|00|28|0|14|D.A.C. ehf|D.A.C. ehf|Galantamín||||11958|17068 035234|M01AB5502 |Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5547|8368|lyfalmen|V2130|7950|0|100|0|50|D.A.C. ehf|D.A.C. ehf|||||5547|8368 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|Lamótrigín||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|V0705|5347|00|56|0|19|Actavis Group hf|Actavis hf|Lamótrigín||3321||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|V0706|8873|00|56|0|37|Actavis Group hf|Actavis hf|Lamótrigín||5919||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|130387|164199|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegaptaníb||130387||130387|164199 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|PCO|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|Digoxín||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|48840|62673|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Fitusambönd||48840||48840|62673 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|968|2154|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||968||968|2154 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|516|1541|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||516||516|1541 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|5700|8576|lyfalmen|||00|60|0|60|Vistor hf|Meda AS|Tenoxíkam||5700||5700|8576 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|236935|296852|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||236935||236935|296852 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|423180|528727|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||423180||423180|528727 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|845950|1055075|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||845950||845950|1055075 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|807|1936|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||807||807|1936 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1289|2590|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1289||1289|2590 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|AstraZeneca A/S DK|Silíkonsambönd||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2545|4294|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2545||2545|4294 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|772|1888|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||772||772|1888 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6912|10220|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6912||6912|10220 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|13824|19396|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||13824||13824|19396 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|27112|35939|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||27112||27112|35939 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|53261|68495|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||53261||53261|68495 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|3060|4993|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3060||3060|4993 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1211|2484|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1211||1211|2484 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|729|1830|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|Trímetóprím||729||729|1830 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2210 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3711 037861|C03AA0301|Aquazið|töflur|25|mg|100|stk|1|glas||C03AA03|01.05.1983|31.03.2009|R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|812|1942|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf||812|812|812|812|1942 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|1960|3500|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|Trímetóprím||1960||1960|3500 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1489|lyfalmen|V0917|1424|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||478||478|1489 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2556|lyfalmen|V0918|2385|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1264||1264|2556 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3506|lyfalmen|V0919|3240|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1964||1964|3506 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1128|2371|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1128||1128|2371 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|230921|289364|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||230921||230921|289364 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|10787|15479|lyfalmen|||00|90|0|90|Icepharma hf|Servier|Perindópríl||10787||10787|15479 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4751|7288|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |Betahistín||4751||4751|7288 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3211|5198|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||3211||3211|5198 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|40764|52619|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||40764||40764|52619 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|70932|90178|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||70932||70932|90178 039575|D01AE1503 |Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|15|0|15|D.A.C. ehf|D.A.C. ehf|Terbínafín||||| 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|6328|9428|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||6328||6328|9428 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1592|3001|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1592||1592|3001 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2442|4154|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2442||2442|4154 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|378|541|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||378||378|541 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|0|0|AGP|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|2685|00|98|0|131|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1630|3052 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|868|1243|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||868||868|1243 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1540|2205|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1540||1540|2205 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3273|5282|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3273||3273|5282 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Gervitár og aðrar óvirkar sam­setningar|||||1579 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|8958|12997|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Rota-veira, veikluð veira||8958||8958|12997 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2977|4880|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||2977||2977|4880 041488|N06AB1002 |Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|24650|32874|lyfalmen|V2172|28617|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Escítalópram||||24650|32874 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4744|8210|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||4744||4744|8210 041795|M02AA1503 |Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||0|100|0|0|D.A.C. ehf|D.A.C. ehf|Díklófenak||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|182804|229776|lyfalmen|||02|100|0|0|Icepharma hf|Schering AG|Gadófosveset||182804||182804|229776 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1369|2698|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól||1369||1369|2698 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|11523|16214|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||11523||11523|16214 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3933|5631|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||3933||3933|5631 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4960|7101|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4960||4960|7101 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4687|6711|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4687||4687|6711 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7106|10174|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||7106||7106|10174 042346|N07BA0137 |Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|42|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042357|N07BA0141 |Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|8158|11680|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||8158||8158|11680 042368|A06AB0602 |Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2297|3958|lyfalmen|||00|500|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2297|3958 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8923|12776|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Kolvetni||8923||8923|12776 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4738|6784|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4738||4738|6784 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3476|4977|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||3476||3476|4977 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2997|4291|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2997||2997|4291 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|10473|14906|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||10473||10473|14906 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4240|6071|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||4240||4240|6071 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2364|3385|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2364||2364|3385 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7816|11191|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Elektrólýtar||7816||7816|11191 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2651|3796|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2651||2651|3796 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|834|1972|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||834||834|1972 042551|B05BB0209 |Glucos 100 mg/ml med Na40 + K20 Fres|irl|0||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3395|4861|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3395|4861 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15948|22040|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||15948||15948|22040 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3684|5275|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3684||3684|5275 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0|Icepharma hf|Fresenius Kabi|||||| 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|339|1300|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||339||339|1300 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3205|4589|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||3205||3205|4589 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3842|6054|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3842||3842|6054 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5892|8436|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||5892||5892|8436 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|608|1665|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||608||608|1665 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1301|2606|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|Estríól||1301||1301|2606 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|13949|19551|lyfalmen|V0011|19492|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||13949||13949|19551 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|5983|8960|lyfalmen|V1300|8960|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Síldenafíl||5983||5983|8960 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|40869|52749|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Írinótekan||40869||40869|52749 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1359|2685|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||1359||1359|2685 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7973|11660|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||7973||7973|11660 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1050|2265|lyfalmen|V0362|2265|00|98|0|65|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||1050|2265 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|868|2018|lyfalmen|V0361|2018|00|98|0|33|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||||868|2018 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|22818|43636|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||22818||22818|43636 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|5076|7729|lyfalmen|V1088|7729|02|10|0|1|Icepharma hf|Vian SA|Ondansetrón||5076||5076|7729 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|8305|12111|lyfalmen|V1089|12111|02|20|0|2|Icepharma hf|Vian SA|Ondansetrón||8305||8305|12111 047042|L04AB0101|Enbrel|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|87750|111116|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||87750||87750|111116 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|913|2079|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Sótalól||913||913|2079 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1192|2458|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|Amoxicillín||1192||1192|2458 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61073 047560|L04AB0101|Enbrel|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|223154|279694|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||223154||223154|279694 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|9296|13456|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|Zafírlúkast||9296||9296|13456 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4743|6791|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|Albúmín||4743||4743|6791 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7487|10720|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Albúmín||7487||7487|10720 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|MAB|0|0|0|100|DKK|2382|4073|lyfalmen|||00|100|0|0|Vistor hf|Meda AB|Klídín og geðlyf||2382||2382|4073 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|14991|20849|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||14991||14991|20849 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|4216|6562|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|Ísósorbíð dínítrat||4216||4216|6562 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1937|3469|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||1937||1937|3469 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|70059|89408|lyfalmen|||00|150|0|38|Icepharma hf|Roche|Mýcófenólsýra||70059||70059|89408 048520|N04BD0104|Selegilin Merck NM|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995|31.03.2009|R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2358|4040|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Selegilín||2358||2358|4040 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|8799|12781|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|Selegilín||8799||8799|12781 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|520|1546|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||520||520|1546 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|20611|27846|lyfalmen|||00|3|0|0|Icepharma hf|Roche Registration Limited|||20611||20611|27846 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2951|4845|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2951||2951|4845 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3740|5916|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||3740||3740|5916 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|11008|15779|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||11008||11008|15779 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|8523|12407|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|Amorolfín||8523||8523|12407 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2277|lyfalmen|V0361|2277|00|98|0|33|Portfarma ehf|Portfarma|Simvastatín||1059||1059|2277 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|V0362|2265|00|98|0|65|Portfarma ehf|Portfarma|Simvastatín||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|2740|lyfalmen|V0367|2740|00|100|0|133|Portfarma ehf|Portfarma|Simvastatín||1400||1400|2740 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4259|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|Ramipríl||2519||2519|4259 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2181|3800|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2181||2181|3800 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|Ramipríl||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5416|8190|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|Ciklospórín||5416||5416|8190 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|19873|26927|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|Ciklospórín||19873||19873|26927 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|16229|21717|lyfalmen|V0718|7760|00|12|0|84|D.A.C. ehf|D.A.C. ehf|Alendrónsýra||15688||15688|21717 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|84977|107981|lyfalmen|||00|300|0|38|Icepharma hf|Roche|Mýcófenólsýra||84977||84977|107981 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8608|12325|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||8608||8608|12325 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|590461|715209|lyfsjukr|||00|112|0|0|Vistor hf|Bayer HealthCare AG|Sorafeníb||572965||572965|715209 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4050|6336|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||4050||4050|6336 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|14444|20168|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||14444||14444|20168 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3355|5393|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||3355||3355|5393 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|10121|14575|lyfalmen|V2120|14301|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||10121||10121|14575 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|516|1541|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||516||516|1541 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1838|3335|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1838||1838|3335 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0|D.A.C. ehf|D.A.C. ehf|Ketóprófen||||| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|9786|14120|lyfalmen|V0391|14120|00|60|0|0|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||9786||9786|14120 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2442|4154|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2442||2442|4154 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986|31.05.2009|R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|466|1473|lyfalmen|||72|25|0|10|Vistor hf|BioPhausia AB|Acetýlcýstein||466||466|1473 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1068|2290|lyfalmen|V1910|2290|00|30|0|30|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1068||1068|2290 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3220|5210|lyfalmen|V1911|5210|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3220||3220|5210 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1645|3073|lyfalmen|V1912|3073|00|30|0|45|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1645||1645|3073 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4759|7299|lyfalmen|V1913|7299|00|100|0|150|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4759||4759|7299 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986|31.05.2009|R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|1764|3234|lyfalmen|||72|100|0|40|Vistor hf|BioPhausia AB|Acetýlcýstein||1764||1764|3234 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|37803|48932|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|Levetíracetam||37803||37803|48932 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|3998|6266|lyfalmen|V0084|6157|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3998||3998|6266 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|1909|3043|lyfalmen|V0308|3043|00|100|0|0|Portfarma ehf|Portfarma|Amlódipín||1623||1623|3043 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|3|0|0|B|0|POF|0|0|0|100|IKR|3111|4428|lyfalmen|V0310|4428|00|100|0|0|Portfarma ehf|Portfarma|Amlódipín||2644||2644|4428 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|416295|520155|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||416295||416295|520155 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|838766|1046131|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||838766||838766|1046131 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|3|0|1|0|1|BSP|0|0|0|100|DKK|848359|1058074|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||848359||848359|1058074 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2|D.A.C. ehf|D.A.C. ehf|Acíklóvír||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|35787|46422|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|Kalsíumfólínat||35787||35787|46422 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|44122|56799|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|Blöndur||44122||44122|56799 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|35449|46002|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|Blöndur||35449||35449|46002 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|47779|61352|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|Kalsíumfólínat||47779||47779|61352 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|41018|52935|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|Blöndur||41018||41018|52935 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34077|44293|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|Blöndur||34077||34077|44293 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|46201|59388|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|Blöndur||46201||46201|59388 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|42984|55383|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|Blöndur||42984||42984|55383 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2669|4462|lyfalmen|V0903|4462|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Zolpidem||2669||2669|4462 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2650|4437|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2650||2650|4437 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|82593|104696|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|Lopinavír||82593||82593|104696 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|6189|9239|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||6189||6189|9239 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|36901|48127|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||36901||36901|48127 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|11433|16356|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||11433||11433|16356 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|35302|46136|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||35302||35302|46136 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|5485|8284|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||5485||5485|8284 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|120616|152034|lyfsjukr|||43|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||120616||120616|152034 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|569|1613|lyfalmen|V0902|1613|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Zolpidem||569||569|1613 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|15814|21873|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||15814||15814|21873 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1250|2537|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1250||1250|2537 054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979|30.04.2009|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1263|2554|lyfalmen|||8|100|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1263||1263|2554 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|863|2012|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||863||863|2012 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2826|4675|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2826||2826|4675 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|1|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|78090|99090|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|Ribavirin||78090||78090|99090 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1324|2637|lyfalmen|||00|200|0|5|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1324||1324|2637 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|13926|26698|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||13926||13926|26698 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8420|14571|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||8420||8420|14571 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|744|1850|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|Erýtrómýcín||744||744|1850 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|12739|18045|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||12739||12739|18045 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|5908|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||3734||3734|5908 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4359|6756|lyfalmen|V0337|6756|00|100|0|50|Actavis Group hf|Actavis hf|Atorvastatín||4359||4359|6756 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|6185|9234|lyfalmen|V0338|9234|00|100|0|100|Actavis Group hf|Actavis hf|Atorvastatín||6185||6185|9234 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|11516|lyfalmen|V0339|11516|00|100|0|200|Actavis Group hf|Actavis hf|Atorvastatín||7867||7867|11516 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1213|2486|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|Erýtrómýcín||1213||1213|2486 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|28577|37446|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||28577||28577|37446 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|264021|330574|lyfsjukr|||00|15|0|30|Icepharma hf|Elan Pharma International|Natalizumab||264021||264021|330574 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|72711|92393|lyfsjukr|||00|30|0|30|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||72711||72711|92393 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|20351|27204|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||20351||20351|27204 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|10814|15331|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||10814||10814|15331 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7041|10081|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||7041||7041|10081 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|5821|8334|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||5821||5821|8334 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|27107|35616|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|Ceftríaxón||27107||27107|35616 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|5353|8105|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5353||5353|8105 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|19046|25897|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||19046||19046|25897 057978|N07BA0301|Champix|filmhtfl|0| |25|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.01.2007|31.03.2009|R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|4843|7413|lyfalmen|||00|25|0|10|Vistor hf|Pfizer Limited|||4843||4843|7413 057987|N07BA0301|Champix|filmhtfl|1|mg|28|stk|1|þpakki||N07BA03|01.01.2007|31.03.2009|R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|5411|8183|lyfalmen|||00|28|0|14|Vistor hf|Pfizer Limited|||5411||5411|8183 057996|N07BA0301|Champix|filmhtfl|1|mg|56|stk|1|þpakki||N07BA03|01.01.2007|31.03.2009|R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|10876|15600|lyfalmen|||00|56|0|28|Vistor hf|Pfizer Limited|||10876||10876|15600 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|22066|29657|lyfalmen|||0|112|0|56|Vistor hf|Pfizer Limited|||||22066|29657 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|466|1473|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||466||466|1473 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|22007|29584|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||22007||22007|29584 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|922|2092|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|Trímetóprím||922||922|2092 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|123892|156113|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||123892||123892|156113 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1557|2953|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1557||1557|2953 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2454|4171|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2454||2454|4171 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4378|6782|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4378||4378|6782 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1538|2928|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|Ísósorbíð dínítrat||1538||1538|2928 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|113436|143413|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||113436||113436|143413 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|33429|43804|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||33429||33429|43804 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|125157|157688|lyfsjukr|||00|30|0|0|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||125157||125157|157688 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|7910|11325|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|Búprenorfín í blöndum||7910||7910|11325 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|822|1956|lyfalmen|||00|98|0|33|Actavis Group PTC ehf|Merck NM AB|Atenólól||822||822|1956 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|17935|24197|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|Búprenorfín í blöndum||17935||17935|24197 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|427797|534792|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||427797||427797|534792 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|216649|271913|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||216649||216649|271913 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|108325|137050|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||108325||108325|137050 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|8327|12141|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|Klómípramín||8327||8327|12141 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1968 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1968 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|3005|5895|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||3005|5895 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1575|3108|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||1575|3108 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|9301|17888|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Animal Health|||||9301|17888 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|8180|11941|lyfalmen|V1030|11299|00|84|0|84|D.A.C. ehf|D.A.C. ehf|Tíbólón||||8180|11941 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7707|11299|lyfalmen|V1030|11299|00|84|0|84|Vistor hf|N.V. Organon|Tíbólón||7707||7707|11299 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||2002 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|188809|236935|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Temsirolímus||188809||188809|236935 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8|Actavis Group hf|Actavis hf|Acetýlsalicýlsýra||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|7209|10321|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||7209||7209|10321 061961|J01XX0901|Cubicin|irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|18940|25448|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|Daptomýcín||18940||18940|25448 061970|J01XX0901|Cubicin|irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|26809|35245|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|Daptomýcín||26809||26809|35245 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|553|1591|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||553||553|1591 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|5082|7737|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||5082||5082|7737 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7603|11158|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||7603||7603|11158 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|8051|11527|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|Metótrexat||8051||8051|11527 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|912|1306|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|Metótrexat||912||912|1306 062711|J01EE0103|Primazol|töflur|480|mg|30|stk|1|glas|80+400 mg|J01EE01|01.10.1995|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|694|1782|lyfalmen|||00|30|0|8|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||694||694|1782 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1165|2421|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1165||1165|2421 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2235|3873|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|||2235||2235|3873 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|19686|34068|vetorma|||16|1000|0|0|Vistor hf|Bayer Animal Health GmbH|||19686||19686|34068 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|USD|2094|3682|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|Gestóden og östrógen||2094||2094|3682 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|16821|23127|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||16821||16821|23127 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5614|8459|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||5614||5614|8459 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2265|3914|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||2265||2265|3914 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team|Laktúlósa|||||2975 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|2264|3913|lyfalmen|V1901|3237|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Deslóratadín||2264||2264|3913 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|5310|8046|lyfalmen|V1902|7544|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Deslóratadín||||5310|8046 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|12007|16816|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||12007||12007|16816 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2771|4795|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2771||2771|4795 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1165|2421|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1165||1165|2421 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2370|4057|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2370||2370|4057 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1186051|1478501|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|||||1186051|1478501 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|474420|592520|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|||||474420|592520 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2562|4317|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2562||2562|4317 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4744204|5908401|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|||||4744204|5908401 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2372103|2955136|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|||||2372103|2955136 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|955|2136|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||955||955|2136 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2657|4446|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||2657||2657|4446 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|14286|19971|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||14286||14286|19971 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5486||5486|7855 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|6|0|6|Vistor hf|Bayer A/S|Klótrímazól||||| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|1|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2982|4887|lyfalmen|V1989|4807|06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||2982||2982|4887 065722|S01EE0101 |Xalatan|augndr|50|mcg/ml|2,5|ml|3|glas||S01EE01|01.05.2009||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|8203|11972|lyfalmen|||06|8|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||||8203|11972 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2332|4005|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|Lósartan||2332||2332|4005 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7875|11527|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||7875||7875|11527 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|36227|46970|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||36227||36227|46970 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|22873|43741|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||22873||22873|43741 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|921|2090|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|Klómípramín||921||921|2090 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|849|1993|lyfalmen|V0908|1993|00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Klómípramín||849||849|1993 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|2471|4194|lyfalmen|V0144|3267|70|30|0|15|D.A.C. ehf|D.A.C. ehf|Amíódarón||2471||2471|4194 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|703|1794|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||703||703|1794 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7768|11382|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |Betahistín||7768||7768|11382 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1324|2637|lyfalmen|||00|100|0|33|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1324||1324|2637 067632|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7440|14343|vetalmen|||0|10|0|0|Dýraheilsa ehf|Laboratorios SYVA S.A.|||||7440|14343 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|827|1963|lyfalmen|V0901|1963|00|50|0|50|D.A.C. ehf|D.A.C. ehf|Nítrazepam||827||827|1963 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7143|10534|lyfalmen|V0552|10534|10|30|0|8|Actavis Group hf|Actavis hf|Flúkónazól||7143||7143|10534 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|26738|35474|lyfalmen|V0557|35474|10|30|0|30|Actavis Group hf|Actavis hf|Flúkónazól||26738||26738|35474 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6669|12875|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||6669||6669|12875 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2225|3860|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|Flekaíníð||2225||2225|3860 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|6282|9365|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Flekaíníð||6282||6282|9365 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|3033|4956|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|Cefalexín||3033||3033|4956 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1516|2898|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|Cefalexín||1516||1516|2898 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||44276||44276|56991 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|33805|43955|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||33805||33805|43955 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7736|11076|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||7736||7736|11076 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5503|7879|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||5503||5503|7879 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9664|13836|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||9664||9664|13836 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6150|8805|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||6150||6150|8805 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|5325|10315|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||5325||5325|10315 070623|C03AA0301|Aquazið|töflur|12,5|mg|100|stk|1|glas||C03AA03|01.03.1984|31.03.2009|R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|748|1855|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||748||748|1855 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|16784|23081|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|Risperídón||16784||16784|23081 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|5638|10911|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||5638||5638|10911 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|Litíum||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|59535|75989|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|Ziconotíð||59535||59535|75989 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|297678|372477|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|Ziconotíð||297678||297678|372477 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8508|16378|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||8508||8508|16378 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|14890|20723|lyfalmen|||00|15|0|5|Icepharma hf|Roche as|Granisetrón||14890||14890|20723 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||20883||20883|28184 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|598|856|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||598||598|856 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|181350|227648|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||181350||181350|227648 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1832|2623|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||1832||1832|2623 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16267|22437|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|Exenatíð||16267||16267|22437 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|16267|22437|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|Exenatíð||16267||16267|22437 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1427|2777|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1427||1427|2777 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|4206|5621|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3523||3523|5621 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1787|3265|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1787||1787|3265 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|333|1292|lyfalmen|||00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||333||333|1292 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|898|2059|lyfalmen|||00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||898||898|2059 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1301|2606|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1301||1301|2606 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|563|1604|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||563||563|1604 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|978|2168|lyfalmen|||00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||978||978|2168 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1941|3474|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1941||1941|3474 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|3921|6161|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3921||3921|6161 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|11418|16335|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||11418||11418|16335 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|5003|7630|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5003||5003|7630 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|14726|20519|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||14726||14726|20519 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|5003|7630|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||5003||5003|7630 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|16529|22764|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||16529||16529|22764 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|5993|8973|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|Sibutramin||5993||5993|8973 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|251|1181|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|Díazepam||251||251|1181 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|508|1530|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||508||508|1530 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|22611|39129|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||22611||22611|39129 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2378|4067|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2378||2378|4067 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|5993|8973|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|Sibutramin||5993||5993|8973 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1478|2488|lyfalmen|V1910|2290|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1214||1214|2488 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1519|2902|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|Ketókónazól||1519||1519|2902 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2091|3374|lyfalmen|V1912|3073|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1867||1867|3374 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2637|4419|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2637||2637|4419 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2925 075382|V01AA0503|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8107||8107|11842 075408|V01AA0504|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8107||8107|11842 075424|V01AA0501|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8107||8107|11842 075440|V01AA0502|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||8107||8107|11842 075465|V04CL0006|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075481|V04CL0004|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075507|V04CL0005|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075523|V04CL0002|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075549|V04CL0008|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075564|V04CL0003|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075580|V04CL0007|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075606|V04CL0001|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||8107||8107|11842 075663|V01AA0302|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8107||8107|11842 075689|V01AA1103|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8107||8107|11842 075705|V01AA1102|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8107||8107|11842 075721|V01AA1101|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||8107||8107|11842 075724|B02BD0402|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|139910|176055|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|Storkuþáttur IX||139910||139910|176055 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2272|4483|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2272||2272|4483 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|24723|32965|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Sítagliptín||24723||24723|32965 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2798|4637|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||2798||2798|4637 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|Portfarma ehf|Portfarma|Risperídón||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|Portfarma ehf|Portfarma|Risperídón||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|Portfarma ehf|Portfarma|Risperídón||2358||2358|4040 076533|N05AB0301 |Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|971|2158|lyfalmen|V2070|2158|00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||||971|2158 076542|N05AB0301 |Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1346|2667|lyfalmen|V2071|2667|00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||||1346|2667 076551|N05AB0301 |Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1919|3445|lyfalmen|V2072|3445|00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||||1919|3445 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7785|13472|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||7785||7785|13472 077215|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|6779|10040|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|||6779||6779|10040 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|720|1817|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||720||720|1817 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|955|1424|lyfalmen|V0609|1424|10|30|0|15|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1424 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|475|1485|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||475||475|1485 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|724|1823|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||724||724|1823 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|1226|2504|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Flúoxetín||1226||1226|2504 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Flúoxetín||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|2977|4880|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Míanserín||2977||2977|4880 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|5615|8039|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||5615||5615|8039 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|16542|22462|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||16542||16542|22462 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|18369|24737|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||18369||18369|24737 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|142631|179443|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|Interferón beta-1b||142631||142631|179443 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|9691|6353|lyfalmen|V0197|5469|00|98|0|98|Icepharma hf|M.S.D.|Lósartan||4062||4062|6353 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2150|3078|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||2150||2150|3078 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3712|5315|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||3712||3712|5315 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|6670|9550|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||6670||6670|9550 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3649|5792|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3649||3649|5792 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|7504|10744|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||7504||7504|10744 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|21787|29310|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|Perfenazín||21787||21787|29310 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|11745|16490|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||11745||11745|16490 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2255|3229|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2255||2255|3229 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2446|4160|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2446||2446|4160 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|6279|9361|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||6279||6279|9361 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3386|5435|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3386||3386|5435 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|33137|57345|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||33137||33137|57345 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|26164|34442|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||26164||26164|34442 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|51976|66578|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||51976||51976|66578 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|38390|49981|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|Natríumhýalúrónat||38390||38390|49981 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|6318|9414|lyfalmen|V1350|9414|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||6318|9414 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|1325|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||357||357|1325 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998|30.04.2009|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|6606|9805|lyfalmen|||00|28|0|37|Vistor hf|Bristol-Myers Squibb|Pravastatín||6606||6606|9805 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2250|3221|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|Mídazólam||2250||2250|3221 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|20872|28171|lyfalmen|V0813|28171|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Olanzapín||20872||20872|28171 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5526|8339|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5526||5526|8339 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9352|13532|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9352||9352|13532 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0|Ísaga ehf|AGA AB|Súrefni||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|3220|5210|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3220||3220|5210 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|628|1693|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||628||628|1693 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|5259|7977|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5259||5259|7977 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|981|2172|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||981||981|2172 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1568|2968|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1568||1568|2968 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4929|7529|lyfalmen|||00|100|0|6|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4929||4929|7529 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5416|8190|lyfalmen|||00|40|0|12|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5416||5416|8190 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14260|19939|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14260||14260|19939 082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.04.2009|R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|27497|36419|lyfalmen|||00|112|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||27497||27497|36419 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|17168|23559|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|Anastrózól||17168||17168|23559 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14893|20727|lyfalmen|V1372|20727|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14893||14893|20727 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6887|10186|lyfalmen|||00|40|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6887||6887|10186 083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.04.2009|R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|26353|34994|lyfalmen|||00|112|0|37|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||26353||26353|34994 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|47208|60959|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|Follitrópín alfa||47208||47208|60959 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|95913|121597|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|Follitrópín alfa||95913||95913|121597 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|83226|105484|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|Ritonavír||83226||83226|105484 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32317|42420|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||32317||32317|42420 083964|L02AE0101|Suprefact|nefúði|0,1|mg/sk|10|g|4|stk|+ sk-dæla|L02AE01|01.10.1987|31.03.2009|R|A|2.5|0|1|0|1|SNO|0|0|0|100|NOK|36627|47468|lyfsjukr|||23|40|0|33|Vistor hf|Sanofi-aventis Norge AS|Búserelín||36627||36627|47468 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8470|12127|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8470||8470|12127 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|291|1235|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||291||291|1235 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|562|1603|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||562||562|1603 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|68821|87550|lyfsjukr|||00|0|0|38|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||68821||68821|87550 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|Kínín||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|89741|113595|lyfsjukr|||00|0|0|50|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||89741||89741|113595 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|106996|135078|lyfsjukr|||00|0|0|62|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||106996||106996|135078 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|23082|30605|lyfsjukr|||00|0|0|12|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||23082||23082|30605 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Kínín||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|34539|44869|lyfsjukr|||00|0|0|19|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||34539||34539|44869 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|45945|59069|lyfsjukr|||00|0|0|25|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||45945||45945|59069 084751|B03XA0301 |Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|13697|18920|lyfsjukr|||00|0|0|8|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13697|18920 084778|B03XA0301 |Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|52213|66873|lyfsjukr|||00|0|0|30|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||52213|66873 084787|B03XA0301 |Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|160810|202076|lyfsjukr|||00|0|0|90|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||160810|202076 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|1009|2210|lyfalmen|||00|10|0|1|Vistor hf|Eisai Ltd|Rúfínamíð||1009||1009|2210 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|11667|16673|lyfalmen|||00|60|0|3|Vistor hf|Eisai Ltd|Rúfínamíð||11667||11667|16673 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|38895|50609|lyfalmen|||00|100|0|29|Vistor hf|Eisai Ltd|Rúfínamíð||38895||38895|50609 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|21128|28489|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||21128||21128|28489 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|6411|7407|lyfalmen|||0|98|0|49|Actavis Group hf|Actavis Group hf|Ómeprazól||4839||4839|7407 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4287|lyfalmen|V2170|4287|0|56|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4287 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4530|6988|lyfalmen|V2171|6988|0|98|0|98|Actavis Group hf|Actavis Group hf|Ómeprazól||||4530|6988 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5306|lyfalmen|||0|28|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5306 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3292|5308|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Levófloxacín||3292||3292|5308 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|32317|42420|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||32317||32317|42420 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|792|1915|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||792||792|1915 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|14185|19528|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||14185||14185|19528 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|21992|29565|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|Menótrópín||21992||21992|29565 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|39127|50898|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|Menótrópín||39127||39127|50898 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5134|5804|lyfalmen|V1911|5210|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3658||3658|5804 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|6173|8179|lyfalmen|V1913|7299|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5408||5408|8179 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8772|12559|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8772||8772|12559 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|14485|19901|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||14485||14485|19901 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|68779|87497|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||68779||68779|87497 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|80261|101792|lyfsjukr|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|||80261||80261|101792 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3502|5593|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|Tíbólón||3502||3502|5593 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|Silíkonsambönd||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|174123|218651|lyfsjukr|||00|60|0|15|Vistor hf|Pfizer Limited|Maravíroc||174123||174123|218651 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|276|1215|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||276||276|1215 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|242|1169|lyfalmen|||00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||242||242|1169 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2871|4736|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2871||2871|4736 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||01|500|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EME|0|0|0|100|SEK|785|1906|lyfalmen|||00|5|0|28|MedFarm ehf|E. Merck AB|Klómífen||785||785|1906 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|16016|22125|lyfalmen|V0560|22125|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||16016||16016|22125 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|26787|35217|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||26787||26787|35217 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|43631|56188|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||43631||43631|56188 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|89309|113057|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||89309||89309|113057 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1379|2712|lyfalmen|||00|120|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1379||1379|2712 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1649|3078|lyfalmen|||14|20|0|20|Vistor hf|Meda AB|Nabúmeton||1649||1649|3078 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|8176|11936|lyfalmen|||14|100|0|100|Vistor hf|Meda AB|Nabúmeton||8176||8176|11936 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|504|1524|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||504||504|1524 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16198|18038|lyfalmen|V1111|14728|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan||12733||12733|18038 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|170332|213931|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||170332|213931 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|53302|56812|lyfalmen|V0561|56812|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||43877||43877|56812 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1310|2618|lyfalmen|V0408|2146|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Estradíól||1310||1310|2618 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|174123|218651|lyfsjukr|||00|60|0|30|Vistor hf|Pfizer Limited|Maravíroc||174123||174123|218651 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2248|3891|lyfalmen|V0352|1798|00|100|0|25|Vistor hf|Ferrosan A/S|Diltíazem||2248||2248|3891 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|44028|56682|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||44028||44028|56682 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|220140|275942|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||220140||220140|275942 090460|L04AB0102|Enbrel (Lyjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|87233|110473|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|Etanercept||87233||87233|110473 090469|L04AB0102|Enbrel (Lyjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|181896|228328|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|Etanercept||181896||181896|228328 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1681|3122|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1681||1681|3122 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|413|1401|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||413||413|1401 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|V0351|3898|10|60|0|30|Actavis Group hf|Actavis hf|Diltíazem||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|143309|180287|lyfsjukr|||00|28|0|0|Lyfjaver ehf|Lyfjaver ehf|Glatíramer acetat||143309||143309|180287 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1869|2343|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |Glímepíríð||1107||1107|2343 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3363|3223|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |Glímepíríð||1756||1756|3223 092005|N06AB1001 |Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|4171|6501|lyfalmen|||00|15|0|30|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||4171|6501 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|143329|180312|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||143329||143329|180312 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|184567|231653|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||184567||184567|231653 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7877|15176|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7877||7877|15176 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7485|10998|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7485||7485|10998 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|11094|15895|lyfalmen|V1400|14385|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Klózapín||||11094|15895 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|28531|37706|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||28531|37706 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|28531|37706|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||28531|37706 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5464|8255|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5464||5464|8255 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|28489|49302|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||28489||28489|49302 093625|B03AA0702|Ferlen-R|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|100|0|50|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|17044|23087|lyfsjukr|||00|5|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||17044||17044|23087 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|19082|25942|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |Oxýcódon||19082||19082|25942 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|62914|80513|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |Oxýcódon||62914||62914|80513 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2222|3856|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2222||2222|3856 093824|N06AB0403|Cipramil (D.A.C.)|filmhtfl|20|mg|28|stk|1|þpakki||N06AB04|01.03.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3425|3739|lyfalmen|V0923|2562|0|28|0|28|D.A.C. ehf|D.A.C. ehf|Cítalópram||2136||2136|3739 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4445|6872|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||4445||4445|6872 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2823|4671|lyfalmen|V0385|4671|23|84|0|84|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2823||2823|4671 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1919|3787|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||1919||1919|3787 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|14008|19625|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||14008||14008|19625 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|20066|27167|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||20066||20066|27167 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|90290|114596|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||90290||90290|114596 094933|A06AH0101|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A06AH01|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|47403|61202|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|||47403||47403|61202 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3562|5674|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|Dísúlfíram||3562||3562|5674 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15950|22043|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15950||15950|22043 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|38413|50009|lyfalmen|||00|56|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||38413||38413|50009 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15950|22043|lyfalmen|||00|28|0|28|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15950||15950|22043 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|34809|45522|lyfalmen|||00|56|0|56|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||34809||34809|45522 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|15950|22043|lyfalmen|||00|28|0|42|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15950||15950|22043 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|61287|78487|lyfalmen|||00|56|0|84|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||61287||61287|78487 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3920|7638|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3920||3920|7638 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|5172|10023|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5172||5172|10023 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|9419|18113|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9419||9419|18113 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2475|3544|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|Mesna||2475||2475|3544 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|14722|20196|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||14722||14722|20196 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|147219|185155|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||147219||147219|185155 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1463|2826|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1463||1463|2826 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17312|23738|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17312||17312|23738 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|850|1866|lyfalmen|V1500|1866|07|5|0|0|D.A.C. ehf|D.A.C. ehf|Fúsidínsýra||756||756|1866 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|1043920|1301548|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1043920|1301548 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|958487|1195184|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||958487|1195184 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|1008621|1257601|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1008621|1257601 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|1107548|1380765|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1107548|1380765 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|17312|23738|lyfalmen|||00|30|0|30|Vistor hf|Novartis Europharm Ltd|Rívastigmín||17312||17312|23738 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1656|3088|lyfalmen|||00|30|0|18|Icepharma hf|Servier|Indapamíð||1656||1656|3088 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|34626|45294|lyfalmen|||00|60|0|60|Vistor hf|Novartis Europharm Ltd|Rívastigmín||34626||34626|45294 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|95477|120736|lyfsjukr|||00|1|0|1|Vistor hf|Pfizer Limited|Anidulafungin||95477||95477|120736 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|3696|3963|lyfalmen|V0426|3963|00|20|0|5|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2301||2301|3963 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1196|2463|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1196||1196|2463 097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|66463|84782|lyfalmen|V0563|76255|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Letrózól||66343||66343|84782 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||13690||13690|18912 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1818|3307|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1818||1818|3307 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9389|7685|lyfalmen|V0714|7685|10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||5044||5044|7685 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12299|10203|lyfalmen|V0715|10203|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||6899||6899|10203 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4366|3990|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |Glímepíríð||2321||2321|3990 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1596|3006|lyfalmen|V1151|3006|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1596||1596|3006 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|7071|10436|lyfalmen|V1110|10436|00|98|0|98|Actavis Group hf|Actavis hf|Valsartan||7071||7071|10436 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|10234|14728|lyfalmen|V1111|14728|00|98|0|196|Actavis Group hf|Actavis hf|Valsartan||10234||10234|14728 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|17687|24205|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||17687||17687|24205 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|3412|5471|lyfalmen|||00|30|0|30|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||3412|5471 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|11355|16250|lyfalmen|||00|100|0|100|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||11355|16250 098486|G03GA002|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|12392|17613|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||12392|17613 098504|G03GA002|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|114947|145294|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||114947|145294 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2450|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||1186||1186|2450 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21777|29297|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||21777||21777|29297 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|770|1885|lyfalmen|V1500|1866|07|5|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||770||770|1885 099476|N05AH0404|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|5513|8322|lyfalmen|V0725|8322|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||5513||5513|8322 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|12588|17857|lyfalmen|V0726|17857|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||12588||12588|17857 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|20370|27546|lyfalmen|V0727|27546|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||20370||20370|27546 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|614|1674|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|Tramadól||614||614|1674 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|46172|59352|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||46172||46172|59352 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|68348|86961|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||68348||68348|86961 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|49995|64111|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||49995||49995|64111 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|111006|140070|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||111006||111006|140070 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14123|19768|lyfalmen|||00|28|0|7|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14123|19768 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|14123|19768|lyfalmen|||00|28|0|14|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||14123|19768 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|13350|18806|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|Lutropin alfa||13350||13350|18806 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997|31.05.2009|R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|2089|3675|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||2089||2089|3675 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18457|25164|lyfalmen|V2160|24703|0|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||18457||18457|25164 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|31112|40919|lyfalmen|||0|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||31112||31112|40919 101386|R06AX1301|Clarityn|saft|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|40050|52047|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|Lutropin alfa||40050||40050|52047 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|133501|168394|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|Lutropin alfa||133501||133501|168394 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|1993|3545|lyfalmen|||00|28|0|19|Vistor hf|Bayer HealthCare AG|Nífedipín||1993||1993|3545 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|6253|9326|lyfalmen|||00|98|0|65|Vistor hf|Bayer HealthCare AG|Nífedipín||6253||6253|9326 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2593|4359|lyfalmen|V1152|4359|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2593||2593|4359 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|9226|13361|lyfalmen|V1153|13361|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||9226||9226|13361 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9469|13690|lyfalmen|V0736|11070|00|100|0|50|D.A.C. ehf|D.A.C. ehf|Tramadól||9469||9469|13690 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|11841|22727|vetalmen|||0|250|0|0|Vistor hf|Boehringer Ingelheim|||||11841|22727 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1452|2811|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1452||1452|2811 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3324|5351|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3324||3324|5351 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2319|3320|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||2319||2319|3320 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|4812|6890|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||4812||4812|6890 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|7623|9968|lyfalmen|V0198|9968|00|98|0|98|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||6726||6726|9968 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|12621|15952|lyfalmen|V0193|15952|00|98|0|196|Portfarma ehf|Portfarma|Lósartan og þvagræsilyf||11136||11136|15952 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|4295|5469|lyfalmen|V0197|5469|00|98|0|98|Portfarma ehf|Portfarma|Lósartan||3411||3411|5469 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2554|3806|lyfalmen|V0507|3806|00|10|0|2|Portfarma ehf|Portfarma|Valacíklóvír||2185||2185|3806 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|10619|13152|lyfalmen|V0508|13112|00|40|0|7|Portfarma ehf|Portfarma|Valacíklóvír||9072||9072|13152 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|15555|19427|lyfalmen|V0955|19163|00|100|0|75|Portfarma ehf|Portfarma|Venlafaxín||13849||13849|19427 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|29604|34998|lyfalmen|V0956|34998|00|100|0|150|Portfarma ehf|Portfarma|Venlafaxín||26356||26356|34998 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma|Bisakódýl|||||1832 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1|Vistor hf|Orion Pharma|Bisakódýl||||| 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.05.2009||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|12525|9819|lyfalmen|V0933|6361|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Sertralín||6616||6616|9819 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3993|6259|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3993||3993|6259 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2756|4580|lyfalmen|||00|21|0|21|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2756||2756|4580 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|8903|12922|lyfalmen|||04|28|0|19|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8903||8903|12922 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5847|8775|lyfalmen|||56|700|0|5|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5847||5847|8775 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|5658|8519|lyfalmen|||10|100|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5658||5658|8519 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5432||5432|7777 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|3998|6266|lyfalmen|V0084|6157|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3998||3998|6266 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2007|31.03.2009|R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|6964|10291|lyfalmen|||0|56|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||6964||6964|10291 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|13928|19525|lyfalmen|V0087|18966|00|100|0|67|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13928||13928|19525 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|18802|25593|lyfalmen|V0089|25593|00|100|0|133|D.A.C. ehf|D.A.C. ehf|Esómeprazól||18802||18802|25593 105315|G03AA0705 |Microgynon (D.A.C.)|töflur|0||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1070|2292|lyfalmen|||23|63|0|84|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||||1070|2292 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|20970|28293|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|Tíagabín||20970||20970|28293 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|17301|23725|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|Tíagabín||17301||17301|23725 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|31457|41349|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|Tíagabín||31457||31457|41349 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|8650|12579|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|Tíagabín||8650||8650|12579 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|15728|21766|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|Tíagabín||15728||15728|21766 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|11533|16491|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|Tíagabín||11533||11533|16491 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4246|6602|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4246||4246|6602 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|14760|20561|lyfalmen|||00|98|0|98|Vistor hf|Novartis Europharm Ltd|||14760||14760|20561 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4894|7482|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|||4894||4894|7482 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|17025|23381|lyfalmen|||00|98|0|196|Vistor hf|Novartis Europharm Ltd|||17025||17025|23381 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2345|4023|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2345||2345|4023 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2555|4308|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2555||2555|4308 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3586|5707|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3586||3586|5707 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|0|100|0|50|Portfarma ehf|Portfarma|Enalapríl||802||802|1929 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|0|100|0|100|Portfarma ehf|Portfarma|Enalapríl||1153||1153|2405 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|0|100|0|200|Portfarma ehf|Portfarma|Enalapríl||2725||2725|4538 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|18774|25241|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||18774||18774|25241 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|10382|14793|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10382||10382|14793 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|17837|24392|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||17837||17837|24392 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|15056|20930|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||15056||15056|20930 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|22667|30405|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||22667||22667|30405 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1923|3450|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||1923||1923|3450 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|17837|24392|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||17837||17837|24392 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis hf|Paracetamól||||| 107583|N03AF0202 |Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|5787|8694|lyfalmen|V2150|7949|00|100|0|30|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||||5787|8694 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||2869 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1117|2356|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|Ranitidín||1117||1117|2356 108209|N02BE0106|Parasupp|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984|31.05.2009|L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|3061|4994|lyfalmen|||63|100|0|33|Vistor hf|Bayer HealthCare AG|Nífedipín||3061||3061|4994 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|4700|7219|lyfalmen|||00|30|0|15|Vistor hf|Novartis Europharm Ltd|Vildagliptín||4700||4700|7219 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|12822|18148|lyfalmen|||00|90|0|45|Vistor hf|Novartis Europharm Ltd|Vildagliptín||12822||12822|18148 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1215|2398|vetalmen|||27|1200|0|0|Icepharma hf|Kela Laboratoria NV|||1215||1215|2398 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1045|2258|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1045||1045|2258 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1589|2997|lyfalmen|||24|120|0|38|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1589||1589|2997 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|Tramadól||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|Tramadól||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|232|1155|lyfalmen|V0775|1144|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||232||232|1155 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|888|2045|lyfalmen|V0780|2025|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||888||888|2045 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|26084|34660|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||26084||26084|34660 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|20883|28184|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||20883||20883|28184 109462|V01AA0301|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|8107|11842|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||8107||8107|11842 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Paracetamól||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|687|1773|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||687||687|1773 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|767|1881|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||767||767|1881 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0|Ísaga ehf|AGA AB|Súrefni||||| 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1654|3085|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||1654||1654|3085 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4847|7418|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|Verapamíl||4847||4847|7418 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|12444|17678|lyfalmen|V1351|17678|00|8|0|16|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||12444|17678 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|805|1933|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||805||805|1933 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|866|2016|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|Gentamícín||866||866|2016 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1376|2708|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||1376||1376|2708 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3811|6012|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3811||3811|6012 112641|M05BA0407 |Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8829|12822|lyfalmen|V0718|7760|00|12|0|84|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||||8829|12822 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10365|14906|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10365|14906 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|28531|37706|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||28531|37706 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|10365|14906|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||10365|14906 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3566|5680|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3566||3566|5680 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|28531|37706|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||28531|37706 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5783|8688|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5783||5783|8688 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|38131|49341|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||38131||38131|49341 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|791186|986894|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|Nilotiníb||791186||791186|986894 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|639|1708|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||639||639|1708 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|933|2107|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||933||933|2107 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1238|2520|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1238||1238|2520 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|796|1921|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||796||796|1921 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|3240|lyfalmen|V0919|3240|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1768||1768|3240 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|2385|lyfalmen|V0918|2385|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1138||1138|2385 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1424|lyfalmen|V0917|1424|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||430||430|1424 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2530|4274|lyfalmen|V0989|4274|06|5|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||2530||2530|4274 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4459|6891|lyfalmen|||0|750|0|3|Vistor hf|Boehringer Ingelheim International|||4459||4459|6891 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1802|3286|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1802||1802|3286 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|13366|18826|lyfalmen|||0|2250|0|10|Vistor hf|Boehringer Ingelheim International|||13366||13366|18826 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|26733|35468|lyfalmen|||0|4500|0|20|Vistor hf|Boehringer Ingelheim International|||26733||26733|35468 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|4459|6891|lyfalmen|||0|1100|0|5|Vistor hf|Boehringer Ingelheim International|||4459||4459|6891 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|13366|18826|lyfalmen|||0|3300|0|15|Vistor hf|Boehringer Ingelheim International|||13366||13366|18826 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|26733|35468|lyfalmen|||0|6600|0|30|Vistor hf|Boehringer Ingelheim International|||26733||26733|35468 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2063|3640|lyfalmen|V1090|3582|06|5|0|17|Icepharma hf|M.S.D.|Dorzólamíð||2063||2063|3640 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1305|2611|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|Cýpróheptadín||1305||1305|2611 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3674|5826|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3674||3674|5826 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0|Icepharma hf|Norpharma |Malatíón||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3942|5644|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3942||3942|5644 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|2061|2951|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2061||2061|2951 116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994|30.04.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994|30.04.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1802|3286|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1802||1802|3286 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10|Icepharma hf|Galderma Nordic AB|||||| 116327|D07AC1301 |Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3218|5207|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3218|5207 116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1792|3272|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1792||1792|3272 116418|D07AC1301 |Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3218|5207|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3218|5207 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Íbúprófen||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Actavis Group hf|Actavis hf|Íbúprófen||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|850|1994|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||850||850|1994 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|476|1486|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Íbúprófen||476||476|1486 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1150|2401|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Íbúprófen||1150||1150|2401 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|19574|26555|lyfalmen|||00|84|0|84|Vistor hf|Pfizer Limited|||||19574|26555 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|6927|10241|lyfalmen|||00|28|0|28|Vistor hf|Pfizer Limited|||||6927|10241 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7358|10826|lyfalmen|||00|28|0|56|Vistor hf|Pfizer Limited|||||7358|10826 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|22171|29788|lyfalmen|||00|84|0|168|Vistor hf|Pfizer Limited|||||22171|29788 116985|N06AX1607 |Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|USD|18088|24173|lyfalmen|V0955|18780|00|98|0|74|D.A.C. ehf|D.A.C. ehf|Venlafaxín||17661||17661|24173 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|39678|51584|lyfalmen|V1702|51584|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||39678||39678|51584 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|39678|51584|lyfalmen|V1703|51584|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||39678||39678|51584 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|9917|19062|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||9917||9917|19062 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|8468|12332|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||8468||8468|12332 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|6271|9350|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||6271||6271|9350 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|13168|18579|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||13168|18579 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|23273|31160|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||23273|31160 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2586|4350|lyfalmen|||10|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2586||2586|4350 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|4024|6301|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4024|6301 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|40241|52285|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||40241|52285 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|46545|60134|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||46545|60134 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10445|18076|vetorma|||00|250|0|0|Vistor hf|Bayer Animal Health GmbH|||10445||10445|18076 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2804|4646|lyfalmen|||61|28|0|28|Vistor hf|Bayer HealthCare AG|Nífedipín||2804||2804|4646 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|4933|7535|lyfalmen|||61|98|0|98|Vistor hf|Bayer HealthCare AG|Nífedipín||4933||4933|7535 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|8021|11725|lyfalmen|||61|98|0|196|Vistor hf|Bayer HealthCare AG|Nífedipín||8021||8021|11725 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|6927|13366|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||6927||6927|13366 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|12149|23313|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||12149||12149|23313 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4294|4776|lyfalmen|V0809|4776|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2900||2900|4776 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|6103|6433|lyfalmen|V0810|6433|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||4121||4121|6433 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|23670|22078|lyfalmen|V0812|22078|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||15978||15978|22078 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18083|17381|lyfalmen|V0815|17381|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12206||12206|17381 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1775|3249|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1775||1775|3249 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15|Actavis Group hf|Actavis hf|Ranitidín||||| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|765|1879|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||765||765|1879 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7663|11239|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||7663||7663|11239 118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|18609|17822|lyfalmen|V0811|17822|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||12560||12560|17822 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|9877|14244|lyfalmen|||00|50|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9877||9877|14244 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|29054|38357|lyfalmen|||00|150|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||29054||29054|38357 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3821|6026|lyfalmen|V1401|5161|00|100|0|8|Lyfjaver ehf|Lyfjaver ehf|Klózapín||||3821|6026 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|11258|16118|lyfalmen|V1400|14385|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Klózapín||||11258|16118 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|90305|114297|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|Panitúmúmab||90305||90305|114297 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|13643|19171|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl og þvagræsilyf||13643||13643|19171 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Portfarma ehf|Portfarma|Íbúprófen||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|488318|610141|lyfalmen|||00|30|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|||||488318|610141 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|488318|610141|lyfalmen|||00|30|0|40|GlaxoSmithKline ehf|Glaxo Group Limited|||||488318|610141 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|1027|2234|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|Cýklópentólat||1027||1027|2234 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|50553|64806|lyfsjukr|||00|1|0|0|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||50553|64806 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|13045|17364|lyfalmen|V1370|16669|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|Galantamín||12192||12192|17364 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|40142|48930|lyfalmen|V1371|48930|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|Galantamín||37546||37546|48930 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|DKK|3452|5525|lyfalmen|V0939|5400|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3452||3452|5525 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|22223|29853|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||22223||22223|29853 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|20872|28171|lyfalmen|V1710|26033|00|100|0|25|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||||20872|28171 121164|A02BC0501 |Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5384|8147|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||5384|8147 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|767|1881|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Tríazólam||767||767|1881 121286|M03AC0901 |Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10604|15069|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||||10604|15069 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|362|1332|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||362||362|1332 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|409|1395|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||409||409|1395 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2153|3762|lyfalmen|V0908|1993|00|100|0|25|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2153||2153|3762 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3328|5357|lyfalmen|||98|30|0|10|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3328||3328|5357 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|592|1644|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Díazepam||592||592|1644 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|924|2094|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Díazepam||924||924|2094 123253|L02BB0301|Casodex|töflur|150|mg|28|stk|1|þpakki||L02BB03|01.06.2009||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|53833|63847|lyfalmen|V0561|53025|00|28|0|84|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||49528||49528|63847 123264|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|13004|18375|lyfalmen|||0|28|0|2|Actavis Group hf|Alpharma ApS|Vankómýcín||||13004|18375 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|IKR|1755|3222|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||1755||1755|3222 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|26044|34610|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|Vankómýcín||||26044|34610 123308|R03BB0404 |Spiriva (Lyfjaver)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.05.2009||R|A|2|0|0|B|0|LVR|0|0|0|100|DKK|7298|10744|lyfalmen|V2110|9897|00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|Tíótrópíumbrómíð||||7298|10744 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|14023|19644|lyfalmen|V1080|19053|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||14023||14023|19644 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|326|1283|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||326||326|1283 123596|N02AA5904|Ibukod sterkar|töflur|0| |100|stk|1|glas|30+200 mg|N02AA59|01.10.1998|31.03.2009|R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|2116|3712|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2116||2116|3712 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|43001|55721|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|Rílúzól||43001||43001|55721 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|974|2162|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||974||974|2162 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1075|2299|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1075||1075|2299 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Enalapríl||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl||1153||1153|2405 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|2520|4260|lyfalmen|V0144|3267|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||2520||2520|4260 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|23234|26512|lyfalmen|V1701|26512|00|28|0|6|D.A.C. ehf|D.A.C. ehf|Aripiprazól||19540||19540|26512 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|19331|20175|lyfalmen|V1732|20175|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14450||14450|20175 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|17152|19986|lyfalmen|V1730|19986|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14298||14298|19986 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|21761|29277|lyfalmen|V1731|21633|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||21761||21761|29277 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|113876|143643|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||113876|143643 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|29225|38253|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||29225|38253 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|27252|35796|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||27252||27252|35796 126561|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|14|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126572|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126583|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|9083|13005|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||9083||9083|13005 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1755|3222|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|Lóperamíð||1755||1755|3222 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|XEU|4356|6752|lyfalmen|V1951|6415|00|28|0|14|D.A.C. ehf|D.A.C. ehf|||||4356|6752 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9367|6433|lyfalmen|V0810|6433|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||4121||4121|6433 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstil|0||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6516|12583|vetalmen|||0|30|0|0|Vistor hf|Boehringer Ingelheim Danmark|||||6516|12583 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|492|1508|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Verapamíl||492||492|1508 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1324|2637|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1324||1324|2637 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|4264|6105|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Mesna||4264||4264|6105 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|31637|17822|lyfalmen|V0811|17822|00|56|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||12560||12560|17822 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|36705|22078|lyfalmen|V0812|22078|00|56|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||15978||15978|22078 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB||||||2808 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5016|7647|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||5016||5016|7647 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|16473|20082|lyfalmen|V0726|17857|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|Quetíapín||14375||14375|20082 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|26076|30516|lyfalmen|V0727|27546|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||22756||22756|30516 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|K|3|0|0|0|0|MYL|0|0|1|100|SEK|2074|3655|lyfalmen|||63|10|0|20|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||||2074|3655 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4295|6669|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4295||4295|6669 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|1|100|SEK|2159|3770|lyfalmen|||63|10|0|3|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||||2159|3770 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|12221|17400|lyfalmen|||0|53|0|21|Vistor hf|Pfizer Limited|||||12221|17400 130772|QI10A0001 |Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|60710|115815|vetalmen|||0|500|0|0|Vistor hf|PHARMAQ AS|||||60710|115815 131136|R03CA0202|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||R03CA02|01.06.2009||R|A|5|0|0|0|0|MYL|0|0|0|100|SEK|2968|4868|lyfalmen|||00|10|0|10|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríð||||2968|4868 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|418|1408|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Fenýtóín||418||418|1408 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|803|1930|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||803||803|1930 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|879|2033|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||879||879|2033 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|972|2159|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||972||972|2159 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5864|8798|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|Estradíól||5864||5864|8798 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|7981|11671|lyfalmen|||0|10|0|0|Vistor hf|Bayer HealthCare AG|||||7981|11671 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|23943|31994|lyfalmen|||0|30|0|0|Vistor hf|Bayer HealthCare AG|||||23943|31994 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|79811|101550|lyfalmen|||0|100|0|0|Vistor hf|Bayer HealthCare AG|||||79811|101550 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|255|1106|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||196||196|1106 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|336|1216|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||277||277|1216 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|13253|18685|lyfalmen|V0192|18685|00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||13253||13253|18685 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|9172|13287|lyfalmen|V0191|13287|00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||9172||9172|13287 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1544|2936|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Kódein||1544||1544|2936 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7920|11588|lyfalmen|||0|30|0|27|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||7920|11588 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||23|8|0|8|Icepharma hf|Napp|Joð/pólývídón||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1170|2428|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Proxýmetakaín||1170||1170|2428 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3|Vistor hf|Abigo Medical AB|Lyfjakol||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|877|2031|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||877||877|2031 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|87351|110619|lyfsjukr|||02|5|0|4|Vistor hf|Chugai sanofi-aventis|Lenógrastím||87351||87351|110619 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|35057|45513|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||35057|45513 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|39167|50630|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||39167|50630 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|43519|56049|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||43519|56049 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|9398|13594|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|Rífampicín||9398||9398|13594 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|118681|149625|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|Voricónazól||118681||118681|149625 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2546|4295|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2546||2546|4295 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|2735|3916|lyfsjukr|||0|5|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||2735|3916 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|4087|5852|lyfsjukr|||0|10|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||4087|5852 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|3|0|1|0|1|AGT|0|0|0|100|XEU|11438|16108|lyfsjukr|||0|25|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||11438|16108 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|177392|222621|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||177312||177312|222621 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997|31.05.2009|R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|4364|6763|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||4364||4364|6763 135111|H01AC0101|Genotropin|sts|0| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|77368|98191|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||77368||77368|98191 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|976|2165|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Verapamíl||976||976|2165 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2254|3899|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2254||2254|3899 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|877|2031|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||877||877|2031 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6523|9692|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|Ísóníazíð||6523||6523|9692 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|107130|135244|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||107130||107130|135244 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|79329|100632|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||79329||79329|100632 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|99536|125790|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||99536|125790 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1593|3002|lyfalmen|V2071|2667|00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||1593||1593|3002 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1056|2273|lyfalmen|V2070|2158|00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||1056||1056|2273 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1581 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1984 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|168098|211150|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|Ranibizumab||168098||168098|211150 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4676|7186|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4676||4676|7186 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|30168|39427|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||30168||30168|39427 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|12441|17357|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||12441||12441|17357 137831|M05BA0303|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|16309|22172|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||16309||16309|22172 137842|M05BA0304|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|21429|28547|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||21429||21429|28547 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2302|3296|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||2302||2302|3296 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|3129|4480|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||3129||3129|4480 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2156|3766|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|Tímólól||2156||2156|3766 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2290|3948|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|Tímólól||2290||2290|3948 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|2913|5041|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||2913||2913|5041 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3203|5187|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3203||3203|5187 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|2982|4887|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|Metformín||2982||2982|4887 140130|V03AB3501 |Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|182734|229371|lyfsjukr|||00|20|0|0|Vistor hf|N.V. Organon|||||182734|229371 140141|V03AB3501 |Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|456836|570628|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|||||456836|570628 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2694|4496|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2694||2694|4496 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1822|3313|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |Pramipexól||1822||1822|3313 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|15105|20673|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||15105||15105|20673 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|681|975|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||681||681|975 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1441|2796|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1441||1441|2796 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|3235|5230|lyfalmen|V2002|5230|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Blöndur||||3235|5230 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1453|2812|lyfalmen|||08|80|0|0|D.A.C. ehf|D.A.C. ehf|Amoxicillín||||1453|2812 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|9506|13610|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|Paracetamól||9506||9506|13610 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|15028|20895|lyfalmen|V0011|19492|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||15028||15028|20895 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|28813|37740|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|Voricónazól||28813||28813|37740 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3523|5621|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |Pramipexól||3523||3523|5621 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4317|5377|lyfalmen|||0|84|0|0|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3343||3343|5377 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2008||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|678|1760|lyfalmen|||00|28|0|7|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||||678|1760 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9202|13328|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|Pramipexól||9202||9202|13328 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|467|1474|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|Própranólól||467||467|1474 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|600|1655|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Própranólól||600||600|1655 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|8400|12027|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||8400||8400|12027 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1051|2267|lyfalmen|V0143|2267|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1051||1051|2267 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2551|4302|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Metenamín||2551||2551|4302 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|830|1967|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Própranólól||830||830|1967 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2196|3820|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||2196||2196|3820 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4929|7057|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||4929||4929|7057 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|781|1900|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|Prednisólón||781||781|1900 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1370|2700|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||1370||1370|2700 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3480|5563|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||3480||3480|5563 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|967|2153|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Trópíkamíð||967||967|2153 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1866|3373|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1866||1866|3373 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2384|4076|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Klónidín||2384||2384|4076 143631|A10BD0701|Janumet|filmhtfl|0||56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|9279|13432|lyfalmen|||0|56|0|0|Icepharma hf|M.S.D.|||||9279|13432 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|11549|6454|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Cítalópram||4137||4137|6454 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|985|2177|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||985||985|2177 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1286|2586|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Litíum||1286||1286|2586 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2983|4888|lyfalmen|V0429|4850|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2983||2983|4888 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4513|6461|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||4513||4513|6461 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|8675|12420|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||8675||8675|12420 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|4036|6317|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||4036||4036|6317 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5084|7740|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||5084||5084|7740 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|15260|20866|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||15260||15260|20866 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|102626|129637|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|Sómatrópín||102626||102626|129637 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28|Actavis Group hf|Actavis Group hf|Ómeprazól||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|64436|82090|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|Sómatrópín||64436||64436|82090 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|41896|54028|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|Sómatrópín||41896||41896|54028 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|962|2146|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||962||962|2146 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|447|1447|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||447||447|1447 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|772|1888|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||772||772|1888 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3403|5458|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3403||3403|5458 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5278|8003|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5278||5278|8003 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0|Vistor hf|Recip AB|Pýrvín||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0|Vistor hf|Recip AB|Pýrvín||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0|Vistor hf|Recip AB|Pýrvín||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|22390|30061|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||22390||22390|30061 146207|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|11119|15711|lyfsjukr|||0|2|0|0|Icepharma hf|Mayne Pharma Plc|Írinótekan||||11119|15711 146218|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|26340|34661|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|Írinótekan||||26340|34661 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|822|1956|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||822||822|1956 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|5164|7394|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||5164|7394 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4356|6237|lyfsjukr|||0|10|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4356|6237 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981||R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1360|2686|lyfalmen|||00|50|0|50|Vistor hf|LEO Pharma A/S|Medroxýprógesterón||1360||1360|2686 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|12993|18044|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||12993||12993|18044 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|20770|27726|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||20770||20770|27726 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|43414|55918|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|Gentamícín||43414||43414|55918 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|120854|152648|lyfalmen|||00|750|0|30|Icepharma hf|Roche as|Dornase alfa||120854||120854|152648 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1134|2379|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1134||1134|2379 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HON|0|0|0|100|SEK|22649|30066|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Nordic AB (V)|Raltítrexed||22649||22649|30066 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|16754|20260|lyfalmen|V2001|20260|00|120|0|120|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||14518||14518|20260 148950|N06DA0203 |Aricept (D.A.C.)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|50075|64528|lyfalmen|V0375|41080|00|98|0|65|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||50075|64528 148961|N06DA0203 |Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|54181|69640|lyfalmen|V0376|45840|00|98|0|131|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||54181|69640 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|16239|22403|lyfalmen|V0192|18685|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan og þvagræsilyf||||16239|22403 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3892|7585|vetalmen|||27|25|0|0|Vistor hf|Bayer Animal Health GmbH|||3892||3892|7585 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1719|3173|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1719||1719|3173 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|14543|20291|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|Rífampicín||14543||14543|20291 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3655|5800|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3655|5800 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7683|11267|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7683||7683|11267 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1108|2344|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1108||1108|2344 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|17086|23457|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||17086|23457 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|52756|67866|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||52756|67866 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|6462|7418|lyfalmen|V0437|6998|00|90|0|90|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||4847||4847|7418 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1722|3177|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1722||1722|3177 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1188|2453|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1188||1188|2453 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|749|1072|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Baklófen||749||749|1072 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4032|6312|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4032||4032|6312 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6239|9307|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6239||6239|9307 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|10447|15017|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||10447||10447|15017 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1696|3142|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|Ítracónazól||1696||1696|3142 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Cetirizín||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1817|3306|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1817||1817|3306 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Cetirizín||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2055|3629|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2055||2055|3629 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1642|3069|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||1642||1642|3069 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|3845|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Cetirizín||2214||2214|3845 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|397175|496350|lyfsjukr|||00|10|0|14|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||397175||397175|496350 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|5684|8554|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|Ítracónazól||5684||5684|8554 153575|M01AH0102 |Celebra (D.A.C.)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|14862|20688|lyfalmen|V2140|20241|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Celekoxíb||||14862|20688 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|7335|10794|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|Hýdroxókóbalamín||7335||7335|10794 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154464|D05AX5203 |Xamiol|hlaup|0||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|5045|7687|lyfalmen|||00|30|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||5045|7687 154475|D05AX5203 |Xamiol|hlaup|0||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|9662|13952|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||9662|13952 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6016|9004|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||6016||6016|9004 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1446|2803|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1446||1446|2803 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5239|7950|lyfalmen|V2130|7950|10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5239||5239|7950 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12743|18050|lyfalmen|||00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||12743||12743|18050 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1286|2586|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1286||1286|2586 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1805|3290|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1805||1805|3290 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|559|1599|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||559||559|1599 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|10754|15434|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|Ítracónazól||10754||10754|15434 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6788|10052|lyfalmen|||00|42|0|14|Icepharma hf|Roche|Orlístat||6788||6788|10052 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9042|13111|lyfalmen|||00|84|0|28|Icepharma hf|Roche|Orlístat||9042||9042|13111 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|346|1310|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||346||346|1310 156964|N07BA0137 |Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156986|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156997|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157020|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157031|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7826|13543|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7826||7826|13543 157419|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|204|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157430|N07BA0140 |Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157463|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||23|96|0|6|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|554|1592|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||554||554|1592 157909|D07XC0101|Diprosalic|áburður|0| |100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3615|5746|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3615||3615|5746 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1081|2307|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1081||1081|2307 158431|B02BD0801 |NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|111030|140100|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||111030|140100 158442|B02BD0801 |NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|222062|278335|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||222062|278335 158453|B02BD0801 |NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|629651|785783|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||629651|785783 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|56758|72531|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||56758|72531 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|89393|113162|lyfsjukr|||0|1|0|1|Vistor hf|Astellas Pharma GmbH|||||89393|113162 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1202|2472|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||1202||1202|2472 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|915|2082|lyfalmen|V0608|2082|10|100|0|50|Actavis Group PTC ehf|Mylan AB|Díklófenak||||915|2082 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2158|3769|lyfalmen|V2003|3769|00|98|0|31|D.A.C. ehf|D.A.C. ehf|Metóprólól||||2158|3769 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3771|5958|lyfalmen|V1050|5958|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||3771|5958 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|7261|10694|lyfalmen|V1051|10694|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||7261|10694 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|10160|14628|lyfalmen|V1052|14628|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||10160|14628 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|12214|17391|lyfalmen|V1053|17391|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||12214|17391 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6974|4768|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2894||2894|4768 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|27613|36563|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||27613||27613|36563 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|14276|12956|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8928||8928|12956 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2019|2613|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1306||1306|2613 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|3495|3739|lyfalmen|V0923|2562|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2136||2136|3739 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|7201|5031|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3088||3088|5031 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|182423|228984|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||182423||182423|228984 159806|QG51BE0001|Streptoc. m/sulfadim., vet.|legstil|0| |50|stk|50|stilar||QG51BE00|01.11.1979|31.03.2009|R|A|2|0|0|0|0|BID|1|0|0|100|DKK|9605|18467|vetalmen|||00|2500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||9605||9605|18467 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2441|3495|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||2441||2441|3495 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|938|2113|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||938||938|2113 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2542|4290|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2542||2542|4290 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|346|1310|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|Díklófenak||||346|1310 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|365|1336|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||365||365|1336 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|80735|102383|lyfsjukr|||0|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||||80735|102383 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|823|1957|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||823||823|1957 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1925|2756|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||1925||1925|2756 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3301|4726|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||3301||3301|4726 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|755|1865|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||755||755|1865 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5219|7923|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|Estradíól||5219||5219|7923 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|64815|82880|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||64815||64815|82880 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|SEK|3643|5216|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||3643||3643|5216 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|SEK|7156|10246|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||7156||7156|10246 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|SEK|22600|30005|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||22600||22600|30005 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2544|4293|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2544||2544|4293 162929|G04CA0205 |Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|5110|7775|lyfalmen|V0437|7775|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||||5110|7775 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2254|3899|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2254||2254|3899 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1280|2577|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||||1280|2577 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1809|3295|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1809||1809|3295 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|218|1136|lyfalmen|||0|20|0|20|Actavis hf|Actavis EAD|||||218|1136 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3003|4916|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3003||3003|4916 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|8140|11887|lyfalmen|||00|454|1|0|Distica|Distica - óskráð lyf|||8140||8140|11887 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2835|4688|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||2835||2835|4688 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2669|4462|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Selegilín||||2669|4462 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|6519|9687|lyfalmen|V0299|9687|98|60|0|20|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6519||6519|9687 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5173|7860|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|Felódipín||5173||5173|7860 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4516|6969|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|Felódipín||4516||4516|6969 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2915|4796|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|Felódipín||2915||2915|4796 165589|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|5|hgl||QH02AB06|01.12.1972|31.03.2009|R|A|5|0|0|0|0|INI|1|0|0|100|DKK|6535|12619|vetalmen|||58|250|0|0|Icepharma hf|Intervet International B.V.|||6535||6535|12619 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|15516|21502|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||15516||15516|21502 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|919|2088|lyfalmen|||00|100|0|50|Vistor hf|UCB Nordic A/S|Meklózín||919||919|2088 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|326|1283|lyfalmen|||00|25|0|12|Vistor hf|UCB Nordic A/S|Meklózín||326||326|1283 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5|Vistor hf|UCB Nordic A/S|Meklózín||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||227395||227395|284974 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2664|4456|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|Dexklórfeníramín||2664||2664|4456 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|953|2134|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||953||953|2134 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2488|4217|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2488||2488|4217 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16357|22549|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||16357||16357|22549 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|26933|35399|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||26933||26933|35399 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|53864|68928|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||53864||53864|68928 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|627|1691|lyfalmen|||00|100|0|25|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||627|1691 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1233|2514|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1233||1233|2514 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3286|5300|lyfalmen|V0789|5300|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3286||3286|5300 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1291|2592|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1291||1291|2592 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7497|11014|lyfalmen|V0713|10714|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||7497||7497|11014 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|48520|62275|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||48520||48520|62275 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|220372|276231|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||220372||220372|276231 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2876|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1500||1500|2876 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|26115|34381|lyfsjukr|||00|5|0|5|Icepharma hf|Roche as|Gancíklóvír||26115||26115|34381 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5612|8456|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5612||5612|8456 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Portfarma ehf|Portfarma|Cíprófloxacín||||1168|2425 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||||647|1718 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Portfarma ehf|Portfarma|Cíprófloxacín||||638|1706 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|A|3|0|0|0|0|POF|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Portfarma ehf|Portfarma|Cíprófloxacín||||393|1374 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3237|5233|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3237||3237|5233 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3476|5557|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3476||3476|5557 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|5140|7816|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||5140||5140|7816 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5259|7977|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|Própafenón||5259||5259|7977 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|9659|13948|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|Própafenón||9659||9659|13948 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2227|3863|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||2227||2227|3863 170697|M05BA0406 |Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|A|2|0|0|E|0|AGP|0|0|0|100|XEU|5099|7760|lyfalmen|V0718|7760|00|12|0|84|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||||5099|7760 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|||10|30|0|2|Icepharma hf|NordMedica A/S|Vankómýcín||10000||10000|14411 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3261|5266|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3261||3261|5266 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3513|5608|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3513||3513|5608 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|732|1834|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||732||732|1834 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3981|6243|lyfalmen|V0709|6241|00|60|0|5|Vistor hf|Janssen-Cilag AB|Tópíramat||3981||3981|6243 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6553|9733|lyfalmen|V0710|9733|00|60|0|10|Vistor hf|Janssen-Cilag AB|Tópíramat||6553||6553|9733 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|48694|62492|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||48694||48694|62492 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|41830|53946|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||41830||41830|53946 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|11833|16898|lyfalmen|V0711|16898|00|60|0|20|Vistor hf|Janssen-Cilag AB|Tópíramat||11833||11833|16898 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|24269|32400|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|Tópíramat||24269||24269|32400 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|72701|92380|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||72701||72701|92380 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|2863|4726|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||2863||2863|4726 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|13251|18682|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||13251||13251|18682 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|7153|10547|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |Hýdrómorphón||7153||7153|10547 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|13651|19180|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |Hýdrómorphón||13651||13651|19180 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|22704|30451|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |Hýdrómorphón||22704||22704|30451 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2468|4190|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2468||2468|4190 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2468|4190|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2468||2468|4190 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3515|5610|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3515||3515|5610 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|903|2066|lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ketókónazól||903||903|2066 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|26064|34635|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |Hýdrómorphón||26064||26064|34635 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|MAB|0|0|1|100|DKK|843|1984|lyfalmen|V0901|1963|00|50|0|50|Vistor hf|Meda AB|Nítrazepam||843||843|1984 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2568|4325|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2568||2568|4325 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3611 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|5481|8278|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||5481||5481|8278 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|984|2176|lyfalmen|||00|10|0|10|Vistor hf|Meda AS|Tenoxíkam||984||984|2176 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|314|1266|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|Zópíklón||314||314|1266 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Parlogis hf|Parlogis - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Parlogis hf|Parlogis - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1482|2122|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|Díazepam||1482||1482|2122 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|601|1656|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||601||601|1656 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|615|1675|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||615||615|1675 174433|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1837|3333|lyfalmen|||00|5|0|25|Vistor hf|Allergan|||||1837|3333 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999|30.04.2009|R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|188|1096|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Zópíklón||188||188|1096 174664|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5388|8152|lyfalmen|||00|15|0|150|Vistor hf|Allergan|||||5388|8152 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2554|3806|lyfalmen|V0507|3806|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||2185||2185|3806 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7474|4776|lyfalmen|V0809|4776|00|28|0|7|Icepharma hf|Eli Lilly Nederland -|Olanzapín||2900||2900|4776 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4411|6826|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4411||4411|6826 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|771|1887|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||771||771|1887 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|681|1344|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||681||681|1344 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|788|1910|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|Betametasón||788||788|1910 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|557|1596|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|Tríamcínólón||557||557|1596 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|11342|15988|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||11342||11342|15988 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|6197|9250|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|Olsalazín||6197||6197|9250 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|16517|22749|lyfalmen|||00|98|0|65|Vistor hf|Bristol-Myers Squibb|Pravastatín||16517||16517|22749 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|937|2112|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón og sýkingalyf||937||937|2112 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|794|1918|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||794||794|1918 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||23|50|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|8023|15454|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||8023||8023|15454 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|32278|42054|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Metótrexat||32278||32278|42054 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|43994|56640|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|Metótrexat||43994||43994|56640 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|SPA|0|0|0|100|DKK|5255|10181|vetalmen|||16|100|0|0|Vistor hf|Schering-Plough A/S|||5255||5255|10181 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5808|11235|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||5808||5808|11235 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1280|2577|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1280||1280|2577 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|902|2064|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||902||902|2064 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1647|3075|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||1647||1647|3075 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|4522|6977|lyfalmen|||98|700|0|5|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4522||4522|6977 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|25115|33453|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Letrózól||25115||25115|33453 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|59494|76255|lyfalmen|V0563|76255|00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Letrózól||59494||59494|76255 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4960|7571|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4960||4960|7571 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A|3|0|0|B|0|MNA|0|1|0|100|SEK|1065|2286|lyfalmen|V1140|2286|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|Míanserín||1065||1065|2286 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|5152|7832|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||5152||5152|7832 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3156|5123|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3156||3156|5123 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2192|3815|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2192||2192|3815 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|51875|66769|lyfalmen|V0561|56812|00|30|0|90|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||51875||51875|66769 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|11214|15829|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|Deferoxamín||11214||11214|15829 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3272|5281|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||3272||3272|5281 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1106|2341|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1106||1106|2341 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|535|1566|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||535||535|1566 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|869|2020|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Indómetacín||869||869|2020 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|471|1480|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Indómetacín||471||471|1480 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1910|3432|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Indómetacín||1910||1910|3432 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4816|6895|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4816||4816|6895 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4912|7033|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4912||4912|7033 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6342|9080|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||6342||6342|9080 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|5|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|534|1565|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klóramfeníkól||534||534|1565 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1731|3189|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1731||1731|3189 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|482|1494|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||482||482|1494 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|726|1826|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|Dexklórfeníramín||726||726|1826 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2085 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1212|2485|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1212||1212|2485 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|1268|1815|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|Metótrexat||1268||1268|1815 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2215|3846|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2215||2215|3846 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|533|1564|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||533||533|1564 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||639||639|1708 194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|39687|51278|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||39687||39687|51278 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1897|3415|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||1897||1897|3415 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4114|6423|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||4114||4114|6423 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|4029|6308|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||4029||4029|6308 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|7815|11446|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||7815||7815|11446 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|2074|3655|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2074||2074|3655 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|847|1990|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||847||847|1990 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|927|2098|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|Lóperamíð||927||927|2098 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|23371|31282|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|Etónógestrel||23371||23371|31282 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|716|1812|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||716||716|1812 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|345|1309|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|Fenýlprópanólamín||345||345|1309 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|816|1948|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|Fenýlprópanólamín||816||816|1948 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1301|2606|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1301||1301|2606 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2754|5417|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2754||2754|5417 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|13112|25148|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||13112||13112|25148 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6282 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|820|1953|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||820||820|1953 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|V0705|5347|00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|917|2085|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||917||917|2085 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4344|6735|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||4344||4344|6735 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2542|4290|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2542||2542|4290 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1516|lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||498||498|1516 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1730|3188|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||1730||1730|3188 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|10936|15483|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúóróúracíl||10936||10936|15483 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|448|641|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||448||448|641 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|39917|51882|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estramústín||39917||39917|51882 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||17114||17114|23174 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|949|2128|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||949||949|2128 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|8254|12041|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||8254||8254|12041 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|60641|77366|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|Abciximab||60641||60641|77366 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4982|7601|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||4982||4982|7601 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|4615|7103|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||4615||4615|7103 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|Skópólamín||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|614|879|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|Fýtómenadíón||614||614|879 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|18816|25293|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||18816||18816|25293 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|544|779|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|Cefazólín||544||544|779 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||8756 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5|Actavis Group hf|Actavis hf|Ranitidín||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|3022|4941|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||3022||3022|4941 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|8471|12336|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||8471||8471|12336 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4429|6851|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4429||4429|6851 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996|30.04.2009|R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|17118|23497|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Alendrónsýra||17118||17118|23497 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|10100|14547|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||10100||10100|14547 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|128805|162230|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||128805||128805|162230 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|257193|322073|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||257193||257193|322073 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|591650|738472|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||591650||591650|738472 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2686|4485|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|Desógestrel og östrógen||2686||2686|4485 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|26782|35529|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||26782||26782|35529 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4384|6790|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4384||4384|6790 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|6847|10132|lyfalmen|V0992|10129|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||6847|10132 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|8961|13001|lyfalmen|V0993|13000|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||8961|13001 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3133|5092|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||3133||3133|5092 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|677|1759|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|Metformín||677||677|1759 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5315|8053|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|Tamsúlósín||5315||5315|8053 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|11513|16464|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11513||11513|16464 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|20050|27147|lyfalmen|V0560|22125|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||20050||20050|27147 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2726|4540|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||2726||2726|4540 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7831|11467|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7831||7831|11467 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|8709|12659|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8709||8709|12659 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|11871|16950|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11871||11871|16950 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4811|7369|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4811||4811|7369 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|39354|51181|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||39354||39354|51181 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|11151|13768|lyfalmen|V0508|13768|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||9526||9526|13768 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|168911|212162|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||168911||168911|212162 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|175936|220908|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||175936||175936|220908 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|220592|276505|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||220592||220592|276505 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1617|3035|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|Díazepam||1617||1617|3035 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1998|3552|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|Díazepam||1998||1998|3552 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|28531|37389|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||28531||28531|37389 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|114562|144497|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||114562||114562|144497 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6428|9563|lyfalmen|||17|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6428||6428|9563 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5996|8977|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||5996||5996|8977 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|16269|3344|lyfalmen|V0367|2685|00|98|0|131|Icepharma hf|M.S.D.|Simvastatín||1845||1845|3344 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6229|9293|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Bambúteról||6229||6229|9293 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1834 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|8298|14360|vetorma|||00|20|0|0|Vistor hf|Bayer Animal Health GmbH|||8298||8298|14360 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Actavis Group hf|Actavis hf|Ketókónazól||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120|Actavis Group hf|Actavis hf|Ketókónazól||||| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|56134|72072|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|Anastrózól||56134||56134|72072 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|784|1547|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||784||784|1547 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|240476|301260|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||240476||240476|301260 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3301|5320|lyfalmen|V2002|5230|00|25|0|5|Vistor hf|AstraZeneca A/S DK|Blöndur||3301||3301|5320 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3724|5894|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|Blöndur||3724||3724|5894 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|6949|10271|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||6949||6949|10271 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2549|4299|lyfalmen|V0388|4299|23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2549||2549|4299 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2329|4001|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2329||2329|4001 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|962|2146|lyfalmen|V0408|2146|00|84|0|84|Vistor hf|BioPhausia AB|Estradíól||962||962|2146 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|684|1769|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|Estradíól||684||684|1769 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|329627|412253|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||329627||329627|412253 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1041|2253|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1041||1041|2253 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12823|18150|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Granisetrón||12823||12823|18150 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2534|4279|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Flúkloxacillín||2534||2534|4279 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3141|5103|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|Nýstatín||3141||3141|5103 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7526|11054|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||7526||7526|11054 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3227|5220|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||3227||3227|5220 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|14503|20241|lyfalmen|V2140|20241|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||14503||14503|20241 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3007|4921|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||3007||3007|4921 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5391|10440|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||5391||5391|10440 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|997|2193|lyfalmen|||00|30|0|30|Icepharma hf|Galderma Nordic AB|Adapalen||997||997|2193 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|190989|239649|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||190989||190989|239649 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|11544|16240|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|Capecitabín||11544||11544|16240 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|61316|78206|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|Capecitabín||61316||61316|78206 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|V0706|8873|00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|9703|14008|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||9703||9703|14008 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1681|3122|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1681||1681|3122 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5988|8966|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||5988||5988|8966 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|390|1370|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||390||390|1370 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|634|1701|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||634||634|1701 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|277|1216|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||277||277|1216 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8|Vistor hf|McNeil Denmark ApS|Nikótín||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|815|1946|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||815||815|1946 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1305|2611|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1305||1305|2611 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|701|1792|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||701||701|1792 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1711|3376|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1711||1711|3376 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5526|10697|vetalmen|||27|20|0|0|Vistor hf|Schering-Plough A/S|||5526||5526|10697 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7528|11056|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|Ísradipín||7528||7528|11056 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1343|2663|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1343||1343|2663 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1777 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|106481|134436|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|Alteplasi||106481||106481|134436 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|674|965|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|Fýtómenadíón||674||674|965 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1793|3274|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1793||1793|3274 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|22117|29721|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||22117||22117|29721 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22173|29790|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22173||22173|29790 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22173|29790|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22173||22173|29790 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22173|29790|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22173||22173|29790 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|22395|30067|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||22395||22395|30067 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|67516|86242|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||67516||67516|86242 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|73228|93354|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||73228||73228|93354 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|78941|100467|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||78941||78941|100467 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7483|10995|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||7483||7483|10995 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|616|1676|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|Indómetacín||616||616|1676 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|2031|3597|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||2031||2031|3597 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|262|1196|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||262||262|1196 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|739|1843|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||739||739|1843 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1141|2389|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1141||1141|2389 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|5238|7949|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5238||5238|7949 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1141|2389|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1141||1141|2389 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3119|5073|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3119||3119|5073 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5607|8449|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5607||5607|8449 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|4141|6460|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||4141||4141|6460 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|3956|6209|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3956||3956|6209 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|13378|18841|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||13378||13378|18841 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3263|5268|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3263||3263|5268 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|11385|21858|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||11385||11385|21858 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987|30.04.2009|R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575|1621|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Atenólól||575||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|10840|15551|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10840||10840|15551 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1180|2442|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Klórókín||1180||1180|2442 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|691|1778|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|Tretínóín||691||691|1778 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|605|1661|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|Baklófen||605||605|1661 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|7865|11261|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|Mídazólam||7865||7865|11261 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|25396|33486|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín||25396||25396|33486 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2001|3556|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2001||2001|3556 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7944|11621|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7944||7944|11621 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|23217|31090|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|Góserelín||23217||23217|31090 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3481|4984|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3481||3481|4984 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10764|20675|vetalmen|||02|100|0|0|Vistor hf|Merial|||10764||10764|20675 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|2004|3560|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||2004||2004|3560 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1281|2579|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||1281||1281|2579 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|112599|142053|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||112599||112599|142053 413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|30132|39382|lyfsjukr|||00|4|0|1|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||30132||30132|39382 413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|30132|39382|lyfsjukr|||00|2|0|1|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||30132||30132|39382 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|2026|3590|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2026||2026|3590 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4883|7467|lyfalmen|||00|90|0|54|Icepharma hf|Servier|Indapamíð||4883||4883|7467 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1560|2957|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1560||1560|2957 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2200|3826|lyfalmen|||5|15|0|15|Vistor hf|Novo-Nordisk|Estradíól||2200||2200|3826 415687|V08BA0101|E-Z-HD|mixtduft|0| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988|30.04.2009|R|A|4|0|0|0|1|EZE|0|0|0|100|USD|15945|21719|lyfsjukr|||08|288|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||15945||15945|21719 415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988|30.04.2009|R|A|2|0|0|0|1|EZE|0|0|0|100|USD|44829|57680|lyfsjukr|||00|384|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||44829||44829|57680 415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988|30.04.2009|R|A|2|0|0|0|1|EZE|0|0|0|100|USD|56038|71635|lyfsjukr|||00|480|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||56038||56038|71635 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|3849|6064|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||3849||3849|6064 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|10195|9968|lyfalmen|V0198|9968|00|98|0|98|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||6726||6726|9968 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3849|6064|lyfalmen|||00|300|1|15|Parlogis hf|Parlogis - óskráð lyf|Ranitidín||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|3108|5058|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||3108||3108|5058 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|26138|34727|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||26138||26138|34727 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1095|2326|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1095||1095|2326 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|568|1121|vetalmen|||00|10|0|0|Vistor hf|Merial|||568||568|1121 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|41566|53617|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Abacavír||41566||41566|53617 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4567|7038|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4567||4567|7038 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1871|3379|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Betametasón||1871||1871|3379 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|9288|13445|lyfalmen|V0299|9687|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||9288||9288|13445 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2095|4134|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2095||2095|4134 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2719|5350|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2719||2719|5350 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4390|6798|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Alfakalsídól||4390||4390|6798 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|10368|14910|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Alfakalsídól||10368||10368|14910 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|71826|91291|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|Doxórúbicín||71826||71826|91291 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|59572|76035|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|Indínavír||59572||59572|76035 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|50348|64551|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||50348||50348|64551 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|840|1980|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||840||840|1980 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|12965|18326|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12965||12965|18326 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|12989|18039|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12989||12989|18039 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3872|6095|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||3872||3872|6095 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|6608|9808|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||6608||6608|9808 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|1788|3267|lyfalmen|V0144|3267|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1788||1788|3267 422121|C07AB0205 |Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1511|2891|lyfalmen|||00|28|0|33|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1511|2891 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3320|5346|lyfalmen|||43|98|0|62|Vistor hf|AstraZeneca A/S DK|Metóprólól||3320||3320|5346 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6540|9715|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|Metóprólól||6540||6540|9715 422402|G03FB0505|Estracomb|forðapl|0| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2758|4583|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Noretísterón og östrógen||2758||2758|4583 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|8498|12373|lyfalmen|||49|100|0|50|Vistor hf|Meda AS|Brómókriptín||8498||8498|12373 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||2179 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|950|2130|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||950||950|2130 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|29489|38899|lyfalmen|||52|100|0|25|Vistor hf|Meda AS|Brómókriptín||29489||29489|38899 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3678|5832|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3678||3678|5832 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|601|1656|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||601||601|1656 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|785|1906|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||785||785|1906 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2541 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1069|2291|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1069||1069|2291 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1061|2280|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1061||1061|2280 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|30991|40451|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||30991||30991|40451 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|48534|62292|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||48534||48534|62292 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|539|1572|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||539||539|1572 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|890|2048|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|Amoxicillín||890||890|2048 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Atenólól||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5973|8946|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5973||5973|8946 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|44682|57814|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||44682||44682|57814 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|6165|9207|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||6165||6165|9207 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1756|2514|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||1756||1756|2514 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2097|3002|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|Mídazólam||2097||2097|3002 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|4115|8010|vetalmen|||27|100|0|0|Vistor hf|Schering-Plough A/S|||4115||4115|8010 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2731|4546|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2731||2731|4546 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|818|1950|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||818||818|1950 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1215|2489|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|Ísósorbíð dínítrat||1215||1215|2489 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|Diltíazem||785||785|1906 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||952||952|2132 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|11890|16976|lyfalmen|V0729|16976|0|100|0|20|Vistor hf|Orion Corporation|Entakapón||11890||11890|16976 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2667|4460|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2667||2667|4460 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4892|7479|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||4892||4892|7479 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6541|9717|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6541||6541|9717 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8190|11955|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||8190||8190|11955 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|9435|13644|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||9435||9435|13644 433359|N02AA0106|Contalgin Uno|forðahlk|200|mg|28|stk|1|þpakki||N02AA01|01.05.1998|31.03.2009|R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|11250|16107|lyfalmen|||00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||11250||11250|16107 433722|J01EE0104|Primazol sterkar|töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1500|lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||486||486|1500 433730|J01EE0104|Primazol sterkar|töflur|960|mg|20|stk|1|glas|160+800 mg|J01EE01|01.07.1989|31.03.2009|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|929|2101|lyfalmen|||00|20|0|10|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||929||929|2101 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1386 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1475|2842|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|Blöndur||1475||1475|2842 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|6236|9303|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6236||6236|9303 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|6236|9303|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||6236||6236|9303 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|11587|16565|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||11587||11587|16565 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5979|8954|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5979||5979|8954 435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998|30.04.2009|R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|2064|3641|lyfalmen|||00|3|0|3|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2064||2064|3641 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4993|7616|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4993||4993|7616 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|7378|9576|lyfalmen|V0725|8322|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6437||6437|9576 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2828|4678|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|Ísósorbíð dínítrat||2828||2828|4678 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4002|6271|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4002||4002|6271 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10553|15161|lyfalmen|V0191|13287|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||10553||10553|15161 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6086|9099|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6086||6086|9099 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|1024|2230|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||1024||1024|2230 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6698|9930|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6698||6698|9930 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12144|17304|lyfalmen|V0728|16972|00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12144||12144|17304 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|25814|34323|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||25814||25814|34323 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|797|1922|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||797||797|1922 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1978|3525|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1978||1978|3525 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|792|1915|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|Naproxen||792||792|1915 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3274|5283|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|Naproxen||3274||3274|5283 436808|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3744|5921|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||3744||3744|5921 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|922|2092|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|Halóperídól||922||922|2092 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3230|5224|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|Halóperídól||3230||3230|5224 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|13637|19163|lyfalmen|V0955|19163|00|100|0|75|Icepharma hf|Wyeth AB|Venlafaxín||13637||13637|19163 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|9725|14038|lyfalmen|||00|28|0|42|Icepharma hf|Wyeth AB|Venlafaxín||9725||9725|14038 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|498|1516|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||498||498|1516 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1293|2595|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|Hýdrókortisón og sýkingalyf||1293||1293|2595 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|5127|7798|lyfalmen|||00|28|0|21|Icepharma hf|Wyeth AB|Venlafaxín||5127||5127|7798 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|17661|24173|lyfalmen|V0955|18780|00|98|0|74|Icepharma hf|Wyeth AB|Venlafaxín||17661||17661|24173 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|33376|43738|lyfalmen|V0956|34298|00|98|0|147|Icepharma hf|Wyeth AB|Venlafaxín||33376||33376|43738 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|36089|47116|lyfalmen|V0956|34998|00|100|0|150|Icepharma hf|Wyeth AB|Venlafaxín||36089||36089|47116 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2109|3702|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough|Lóratadín||2109||2109|3702 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6368|9482|lyfalmen|V0984|3662|00|100|0|100|Vistor hf|Schering-Plough|Lóratadín||6368||6368|9482 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2308|3972|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2308||2308|3972 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|10342|14875|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||10342||10342|14875 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2287 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1592|2279|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1592||1592|2279 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2513|3598|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2513||2513|3598 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|Díklófenak||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1556|2952|lyfalmen|V0221|2940|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||1556||1556|2952 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1277|2573|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|Blöndur||1277||1277|2573 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0|Aco Hud Nordic AB|ACO Hud AB|Permetrín||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|889|2047|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||889||889|2047 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|30558|39912|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zídóvúdín||30558||30558|39912 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3941|6189|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|Glúkagon||3941||3941|6189 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|34099|44638|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||34099||34099|44638 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|48519|62274|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|Stavúdín||48519||48519|62274 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|49212|63136|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|Stavúdín||49212||49212|63136 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|3481|5564|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3481||3481|5564 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3068|5004|lyfalmen|||00|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3068||3068|5004 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|19519|26169|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||19519||19519|26169 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1810|3297|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1810||1810|3297 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|13170|6058|lyfalmen|V0411|5689|10|98|0|98|Icepharma hf|M.S.D.|Fínasteríð||3845||3845|6058 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1554|3067|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1554||1554|3067 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4345|6737|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4345||4345|6737 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1851|3352|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||1851||1851|3352 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|12112|17264|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12112||12112|17264 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6909|10216|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||6909||6909|10216 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8464|12326|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||8464||8464|12326 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10163|14632|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||10163||10163|14632 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|V0352|1798|00|100|0|25|Actavis Group hf|Actavis hf|Diltíazem||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|563|1604|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||563||563|1604 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1099|2332|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1099||1099|2332 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6496|9656|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||6496||6496|9656 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2534|4279|lyfalmen|V0712|2640|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|Baklófen||2534||2534|4279 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|846|1988|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|Atenólól||||846|1988 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1242|2526|lyfalmen|||00|98|0|131|Actavis Group PTC ehf|Merck NM AB|Atenólól||1242||1242|2526 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5960|8533|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5960||5960|8533 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2233|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1173|1769|lyfalmen|V0902|1613|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||684||684|1769 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3699|5118|lyfalmen|V0903|4462|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||3152||3152|5118 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6153|8354|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5537||5537|8354 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|20412|26699|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||19690||19690|26699 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|17835|24390|lyfalmen|V0552|10534|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||17835||17835|24390 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1249|2535|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Ketórólak||1249||1249|2535 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|59731|76550|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||59731||59731|76550 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|13767|19325|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|Imikvímóð||13767||13767|19325 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||R|A|3|0|0|0|0|LCF|0|0|0|100|DKK|3249|5249|lyfalmen|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||3249||3249|5249 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2748|4570|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |Oxýcódon||2748||2748|4570 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9043|13112|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |Oxýcódon||9043||9043|13112 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2587|4351|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||2587||2587|4351 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|5190|7883|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |Oxýcódon||5190||5190|7883 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2743 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|16430|22640|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |Oxýcódon||16430||16430|22640 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|10454|15027|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |Oxýcódon||10454||10454|15027 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|28208|37304|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|Oxýcódon||28208||28208|37304 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|3882|5558|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||3882||3882|5558 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2472|4195|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2472||2472|4195 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|10925|8662|lyfalmen|||00|98|0|65|Icepharma hf|M.S.D.|Simvastatín||5764||5764|8662 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|16527|22761|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||16527||16527|22761 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|46794|60444|lyfalmen|V0375|41080|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||46794||46794|60444 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|18646|25399|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||18646||18646|25399 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|51556|66372|lyfalmen|V0376|45840|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||51556||51556|66372 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|53559|68548|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||53559||53559|68548 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1176|2321|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1176||1176|2321 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|907|2071|lyfalmen|||00|30|0|5|Vistor hf|Bayer HealthCare AG|Acarbósa||907||907|2071 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|3257|5260|lyfalmen|||00|120|0|20|Vistor hf|Bayer HealthCare AG|Acarbósa||3257||3257|5260 455428|B03XA0103|NeoRecormon|sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|68777|87495|lyfsjukr|||00|3|0|30|Icepharma hf|Roche|Epóetín||68777||68777|87495 455527|B03XA0103|NeoRecormon|sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|136749|172120|lyfsjukr|||00|3|0|60|Icepharma hf|Roche|Epóetín||136749||136749|172120 455576|B03XA0103|NeoRecormon|sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|223750|280436|lyfsjukr|||00|5|0|10|Icepharma hf|Roche|Epóetín||223750||223750|280436 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|23581|31543|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||23581||23581|31543 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1073|2296|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group hf|Doxýcýklín||1073||1073|2296 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1170|2428|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis Group hf|Doxýcýklín||1170||1170|2428 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis Group hf|Doxýcýklín||2563||2563|4318 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4356|6237|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4356||4356|6237 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4356|6237|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4356||4356|6237 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4756|6809|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4756||4756|6809 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4756|6809|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4756||4756|6809 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7120|10194|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7120||7120|10194 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7120|10194|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7120||7120|10194 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|7120|10194|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||7120||7120|10194 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8913|12761|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8913||8913|12761 457127|N05BA1202|Paxal|töflur|0,25|mg|20|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|117|999|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|Alprazólam||117||117|999 457135|N05BA1202|Paxal|töflur|0,25|mg|50|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|246|1174|lyfalmen|||00|50|0|12|Actavis Group hf|Actavis hf|Alprazólam||246||246|1174 457143|N05BA1202|Paxal|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|461|1466|lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf|Alprazólam||461||461|1466 457150|N05BA1202|Paxal|töflur|0,5|mg|20|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|199|1110|lyfalmen|||00|20|0|10|Actavis Group hf|Actavis hf|Alprazólam||199||199|1110 457192|N05BA1202|Paxal|töflur|0,5|mg|50|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|440|1437|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis hf|Alprazólam||440||440|1437 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8689|12440|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8689||8689|12440 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11551|16248|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11551||11551|16248 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|1046|2260|lyfalmen|||00|25|0|5|Vistor hf|Astra|Clómetíazól||1046||1046|2260 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1550|2944|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|Pívmecillínam||1550||1550|2944 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2254|3899|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|Pívmecillínam||2254||2254|3899 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9395|13590|lyfalmen|V0456|13590|00|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||9395||9395|13590 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11643|16363|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11643||11643|16363 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11643|16363|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11643||11643|16363 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|11643|16363|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||11643||11643|16363 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|13851|19112|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||13851||13851|19112 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1530|2191|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1530||1530|2191 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|91852|116223|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||91852||91852|116223 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1876|2686|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1876||1876|2686 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2173|3789|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2173||2173|3789 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2382|4073|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2382||2382|4073 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2377|4066|lyfalmen|||00|30|0|8|Vistor hf|Meda AS|Tranexamsýra||2377||2377|4066 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4834|7400|lyfalmen|||00|60|0|15|Vistor hf|Meda AS|Tranexamsýra||4834||4834|7400 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1082|2309|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1082||1082|2309 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4565|7035|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4565||4565|7035 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1619|3037|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||1619||1619|3037 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2943|4834|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|Amoxicillín||2943||2943|4834 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|19474|26113|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||19474||19474|26113 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6530|9702|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||6530||6530|9702 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|77888|98838|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||77888||77888|98838 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|76925|97639|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||76925||76925|97639 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|191005|239669|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||191005||191005|239669 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|671|1751|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||671||671|1751 462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995|30.04.2009|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||2216||2216|3848 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|671|1751|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||671||671|1751 462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995|30.04.2009|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||2216||2216|3848 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7649|11220|lyfalmen|||56|7|0|7|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7649||7649|11220 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|7211|13907|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7211||7211|13907 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5752|11128|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5752||5752|11128 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1903|3423|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Ovation Healthcare International Ltd.|Melperón||1903||1903|3423 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|K|2|0|0|0|0|INI|0|0|0|100|DKK|1278|2522|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1278||1278|2522 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1207|2382|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1207||1207|2382 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1293|2552|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1293||1293|2552 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|681|1344|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||681||681|1344 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|807|1936|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||807||807|1936 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2832|4684|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2832||2832|4684 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1716|3169|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1716||1716|3169 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6890|10190|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6890||6890|10190 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3301|5320|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||3301||3301|5320 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8514|12394|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8514||8514|12394 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5284|8011|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5284||5284|8011 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|5140|7816|lyfalmen|||64|100|0|50|Vistor hf|Meda AS|Móklóbemíð||5140||5140|7816 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|17065|23113|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||17065||17065|23113 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|26745|35165|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||26745||26745|35165 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|28958|37920|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|Interferón alfa-2b||28958||28958|37920 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|47169|60593|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|Interferón alfa-2b||47169||47169|60593 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|40311|52372|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|Sirolimus||40311||40311|52372 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|16610|22864|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16610||16610|22864 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|96553|122076|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|Interferón alfa-2b||96553||96553|122076 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|31626|41559|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||31626||31626|41559 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|744|1065|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|Halóperídól||744||744|1065 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6893|6902|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4467||4467|6902 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|434|621|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||434||434|621 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|12026|6568|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4221||4221|6568 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|25358|13428|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||9276||9276|13428 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10932|15676|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||10932||10932|15676 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|3122|5077|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|Tramadól||3122||3122|5077 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|12724|18026|lyfalmen|V0738|14309|00|100|0|67|Icepharma hf|Grunenthal|Tramadól||12724||12724|18026 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2441|4153|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|Tramadól||2441||2441|4153 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9661|13951|lyfalmen|V0736|11070|00|100|0|50|Icepharma hf|Grunenthal|Tramadól||9661||9661|13951 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1659|3092|lyfalmen|V0733|2543|00|20|0|7|Icepharma hf|Grunenthal|Tramadól||1659||1659|3092 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6599|9796|lyfalmen|V0734|7506|00|100|0|33|Icepharma hf|Grunenthal|Tramadól||6599||6599|9796 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5418|8193|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5418||5418|8193 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6223||6223|8910 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||7625||7625|10917 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9018||9018|12912 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9600||9600|13745 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2141|3746|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||2141||2141|3746 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2514 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2288|3945|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2288||2288|3945 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|5120|9924|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||5120||5120|9924 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2201|3827|lyfalmen|V2003|3769|43|98|0|31|Vistor hf|AstraZeneca A/S DK|Metóprólól||2201||2201|3827 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2509|4245|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2509||2509|4245 473348|A03AA0402|Spasmerin|töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|957|2139|lyfalmen|||00|50|0|22|Actavis Group hf|Actavis hf|Mebeverín||957||957|2139 473371|A03AA0402|Spasmerin|töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1680|3120|lyfalmen|||00|100|0|45|Actavis Group hf|Actavis hf|Mebeverín||1680||1680|3120 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|13807|19057|lyfsjukr|||00|400|0|0|Vistor hf|Meda AB|Dextran||13807||13807|19057 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|990|2184|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||990||990|2184 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|44812|57658|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Nevírapín||44812||44812|57658 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1991|3542|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|Mómetasón||1991||1991|3542 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|1|Actavis Group hf|Actavis Group hf|Paracetamól||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|Warfarín||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4029|6308|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|Estradíól||4029||4029|6308 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|224|1144|lyfalmen|V0775|1144|00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||224||224|1144 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|312|1264|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||312||312|1264 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|873|2025|lyfalmen|V0780|2025|00|100|0|33|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||873||873|2025 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|6708|9943|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl||6708||6708|9943 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3294|5310|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|Formóteról||3294||3294|5310 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|4406|6820|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|Formóteról||4406||4406|6820 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|12864|18201|lyfalmen|||00|98|0|196|Icepharma hf|Roche|Cílazapríl||12864||12864|18201 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|5998|8980|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||5998||5998|8980 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|5093|7752|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5093||5093|7752 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1158|2412|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1158||1158|2412 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6720|9960|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6720||6720|9960 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|10211|14697|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|Quetíapín||10211||10211|14697 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4545|7008|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4545||4545|7008 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|9859|14220|lyfalmen|||00|98|0|131|Vistor hf|Meda AS|Benazepríl||9859||9859|14220 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|21151|28518|lyfalmen|||00|98|0|261|Vistor hf|Meda AS|Benazepríl||21151||21151|28518 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4562|7031|lyfalmen|||00|28|0|28|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4562||4562|7031 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|11811|16868|lyfalmen|||00|84|0|84|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||11811||11811|16868 481168|N06AX1201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|7611|11169|lyfalmen|||00|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||||7611|11169 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|11746|16780|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||11746||11746|16780 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|42610|54917|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Clostridium botulinum toxín-A||42610||42610|54917 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|66761|85302|lyfalmen|V0557|33109|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||66761||66761|85302 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3870|5541|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3870||3870|5541 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5866|8399|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5866||5866|8399 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|88509|112061|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|Triptórelín||88509||88509|112061 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|7193|10602|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Fínasteríð||7193||7193|10602 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1301|2606|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|Benzýdamín||1301||1301|2606 484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004|30.04.2009|R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||543||543|777 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|717|1813|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||717||717|1813 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|705|1797|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||705||705|1797 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2677|4473|lyfalmen|||00|30|0|15|Icepharma hf|Servier|Perindópríl||2677||2677|4473 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|3907|6142|lyfalmen|||00|30|0|30|Icepharma hf|Servier|Perindópríl||3907||3907|6142 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|789|1911|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|Nítrófúrantóín||789||789|1911 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|848|1991|lyfalmen|||00|20|0|10|Vistor hf|Meda AB|Nabúmeton||848||848|1991 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2526|4268|lyfalmen|||00|60|0|30|Vistor hf|Meda AB|Nabúmeton||2526||2526|4268 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|10471|15050|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||10471||10471|15050 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|18901|25717|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||18901||18901|25717 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|960|1474|lyfalmen|V0609|1424|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2373|4061|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2373||2373|4061 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2782|4616|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2782||2782|4616 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|9225|13359|lyfalmen|||00|5|0|2|Icepharma hf|Roche as|Granisetrón||9225||9225|13359 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5076|7729|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||5076||5076|7729 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11643|11086|lyfalmen|V0337|6756|00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||7550||7550|11086 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|7877|11530|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||7877||7877|11530 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|16523|15100|lyfalmen|V0338|9234|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||10508||10508|15100 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|12227|17408|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12227||12227|17408 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|21015|18689|lyfalmen|V0339|11516|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||13256||13256|18689 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|23706|31699|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|Rívastigmín||23706||23706|31699 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|52056|66677|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|BCG bóluefni||52056||52056|66677 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3650|5794|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3650||3650|5794 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11213|16057|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Ómeprazól||11213||11213|16057 492546|A02BC0102 |Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1396|2735|lyfalmen|V1140|2540|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Míanserín||1396||1396|2735 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4606|7091|lyfalmen|||00|28|0|19|Vistor hf|Bristol-Myers Squibb|Pravastatín||4606||4606|7091 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1598|3009|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1598||1598|3009 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4224|6573|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Pízótífen||4224||4224|6573 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|93962|118850|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||93962||93962|118850 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|234908|294328|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||234908||234908|294328 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2439|4150|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2439||2439|4150 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2783|4617|lyfalmen|V0408|2146|23|84|0|84|Vistor hf|Novo-Nordisk|Estradíól||2783||2783|4617 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3530|5631|lyfalmen|V0388|4299|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3530||3530|5631 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3400|5454|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||3400||3400|5454 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|18651|25405|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||18651||18651|25405 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7254|10684|lyfalmen|V1088|7729|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7254||7254|10684 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10364|14905|lyfalmen|V1089|12111|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||10364||10364|14905 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|18457|25164|lyfalmen|V2160|24703|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||18457||18457|25164 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|31112|40919|lyfalmen|||00|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||31112||31112|40919 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2846|4703|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2846||2846|4703 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4544|8827|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||4544|8827 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|4111|6419|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||4111||4111|6419 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|1038|2249|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||1038||1038|2249 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3257|5260|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3257||3257|5260 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|600|1655|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||600||600|1655 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|911|2077|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||911||911|2077 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3471|5551|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3471||3471|5551 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Enalapríl||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|00|100|0|50|Actavis Group hf|Actavis hf|Enalapríl||802||802|1929 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|00|100|0|200|Actavis Group hf|Actavis hf|Enalapríl||2725||2725|4538 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|Klórhexidín||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|785|1906|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||785||785|1906 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1463|2826|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|Betametasón||1463||1463|2826 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|19691|26700|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||19691||19691|26700 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|21228|28614|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||21228||21228|28614 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|28724|37946|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||28724||28724|37946 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|33008|43280|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||33008||33008|43280 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|785|1906|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||785||785|1906 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3810|6011|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3810||3810|6011 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2265|3914|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2265||2265|3914 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3208|5194|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|Maprótilín||3208||3208|5194 502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986|30.04.2009|R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|3977|6237|lyfalmen|||00|100|0|53|Vistor hf|Schering-Plough|Perfenazín||3977||3977|6237 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|33207|43210|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|Triptórelín||33207||33207|43210 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2227|3863|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2227||2227|3863 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2389|4082|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|Estríól||2389||2389|4082 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977|31.05.2009|R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1324|2637|lyfalmen|||10|50|0|50|Vistor hf|Schering-Plough|Dexklórfeníramín||1324||1324|2637 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007|31.05.2009|R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|617|1678|lyfalmen|||00|50|0|0|Vistor hf|Schering-Plough|Dexklórfeníramín||617||617|1678 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1373|2704|lyfalmen|||00|100|0|30|Icepharma hf|Roche|Brómazepam||1373||1373|2704 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8827|12819|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|Maprótilín||8827||8827|12819 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3553|5087|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||3553||3553|5087 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|6917|9903|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||6917||6917|9903 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|12273|17147|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||12273||12273|17147 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|3359|4809|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|Gentamícín||3359||3359|4809 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|31144|40642|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Ísóflúran||31144||31144|40642 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2633|4413|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||2633||2633|4413 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12|Vistor hf|Orion Pharma|Bisakódýl||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|430|1424|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|Bisakódýl||430||430|1424 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1225 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5211 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|9773|16913|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||9773||9773|16913 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|2703|5320|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||2703||2703|5320 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|2749|4571|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|Verapamíl||2749||2749|4571 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5494|10636|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||||5494|10636 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4406|8564|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||4406||4406|8564 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|13631|26136|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||13631||13631|26136 508952|G03FB0902|Nuvelle|töflur|0| |84|stk|1|þpakki||G03FB09|01.08.1997|30.04.2009|R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2623|4400|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||2623||2623|4400 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|10730|15402|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10730||10730|15402 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon|Estríól|||||2804 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|441|1439|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||441||441|1439 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|497|1515|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||497||497|1515 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|364|1334|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||364||364|1334 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|441|1439|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||441||441|1439 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|48240|61926|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín og lamívúdín||48240||48240|61926 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|14129|19458|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|Epóetín||14129||14129|19458 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|25703|33868|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|Epóetín||25703||25703|33868 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|32987|42936|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|Epóetín||32987||32987|42936 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|54118|69244|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|Epóetín||54118||54118|69244 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|104862|132421|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|Epóetín||104862||104862|132421 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|264248|330856|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|Epóetín||264248||264248|330856 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4480|5689|lyfalmen|V0411|5689|00|98|0|98|Actavis Group hf|Actavis hf|Fínasteríð||3573||3573|5689 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3065|5000|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |||3065||3065|5000 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2894|4768|lyfalmen|V0385|4671|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2894||2894|4768 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|20770|27726|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||20770||20770|27726 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|12993|18044|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||12993||12993|18044 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|10223|14595|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||10223||10223|14595 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1950|3487|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Terbútalín||1950||1950|3487 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2257|3903|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2257||2257|3903 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5414|8187|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5414||5414|8187 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|1794|3275|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||1794||1794|3275 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4238|6592|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|Repaglíníð||4238||4238|6592 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4974|7590|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|Repaglíníð||4974||4974|7590 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|6118|9143|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|Repaglíníð||6118||6118|9143 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|986|2178|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|Díklófenak||986||986|2178 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|4690|7205|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|Díklófenak||4690||4690|7205 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2241|3882|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|Desógestrel||2241||2241|3882 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|984|2176|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||984||984|2176 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|8895|12911|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||8895||8895|12911 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5174|7862|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5174||5174|7862 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5844|8771|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5844||5844|8771 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17721|24248|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||17721||17721|24248 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|6272|9352|lyfalmen|V1300|8960|00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||6272||6272|9352 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17340|23773|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||17340||17340|23773 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1623|3043|lyfalmen|V0308|3043|00|100|0|100|Actavis Group hf|Actavis hf|Amlódipín||1623||1623|3043 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2644|4428|lyfalmen|V0310|4428|00|100|0|200|Actavis Group hf|Actavis hf|Amlódipín||2644||2644|4428 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|397|1379|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||397||397|1379 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|36315|47397|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|Pramipexól||36315||36315|47397 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8588|16530|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8588||8588|16530 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|3573|5689|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3573||3573|5689 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|285574|357407|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|Basiliximab||285574||285574|357407 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|434|1429|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||434||434|1429 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1791|3271|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||1791||1791|3271 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|10467|15045|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||10467||10467|15045 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|926|2097|lyfalmen|V0732|2097|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||926||926|2097 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9554|13806|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||9554||9554|13806 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|399|1382|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||399||399|1382 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1253 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1217|2492|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1217||1217|2492 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|25653|34123|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|Flútamíð||25653||25653|34123 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|998|2195|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||998||998|2195 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2536|4282|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2536||2536|4282 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1147 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1127 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1089|2318|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1089||1089|2318 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1086|2314|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1086||1086|2314 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|11839|16906|lyfalmen|||00|30|0|10|Vistor hf|Cephalon France (V)|Modafinil||11839||11839|16906 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|7839|11478|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||7839||7839|11478 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4942|7547|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4942||4942|7547 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|SPA|0|0|0|100|DKK|7163|13816|vetalmen|||16|188|0|0|Vistor hf|Schering-Plough A/S|||7163||7163|13816 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4384|6790|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4384||4384|6790 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|14609|20056|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||14609||14609|20056 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1305|2611|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Emedastín||1305||1305|2611 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|2061|2951|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|Búprenorfín||2061||2061|2951 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4596|8926|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4596||4596|8926 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3959|7712|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||3959||3959|7712 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5271|7547|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|Búprenorfín||5271||5271|7547 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|85903|108817|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Fosfenýtóín||85903||85903|108817 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|10381|14792|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||10381||10381|14792 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|28150|36914|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||28150||28150|36914 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|56300|71961|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||56300||56300|71961 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3710|5875|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3710||3710|5875 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2655|4443|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||2655||2655|4443 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|9737|13941|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |Nevírapín||9737||9737|13941 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|337|1298|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||337||337|1298 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1793|3274|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|Terbútalín||1793||1793|3274 534537|J01EE0103|Primazol|töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1486|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||476||476|1486 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|Bioglan Pharma AB|Dísúlfíram í blöndum||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|6153|9190|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6153||6153|9190 536029|S01EB0105|Isopto Carpine|augndr|10|mg/ml|10|ml|1|glas||S01EB01|01.03.2000|31.03.2009|R|A|4|0|0|*|0|ALC|0|0|0|100|USD|347|1311|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||347||347|1311 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|460|1465|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||460||460|1465 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|587|1637|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||587||587|1637 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|15293|21225|lyfalmen|||52|100|0|12|Vistor hf|Meda AS|Brómókriptín||15293||15293|21225 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||675 537720|L01CB0101|Vepesid|hylki|100|mg|10|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13691|18913|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|||13691||13691|18913 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon|Estríól|||||2366 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|5|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|10|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|133808|168458|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|Interferón beta-1a||133808||133808|168458 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10191|14670|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10191||10191|14670 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|188|1096|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|Díazepam||188||188|1096 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|410|1397|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|Díazepam||410||410|1397 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2733|4549|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2733||2733|4549 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2995|4905|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2995||2995|4905 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|8392|12229|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||8392||8392|12229 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1898|3416|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||1898||1898|3416 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|10218|14707|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||10218||10218|14707 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|16550|22790|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||16550||16550|22790 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1608|3023|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|Verapamíl||1608||1608|3023 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4729|7258|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Pindólól||4729||4729|7258 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Actavis Group hf|Actavis hf|Dífenhýdramín í blöndum||||| 543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|23337|30922|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||23337||23337|30922 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|22|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|9|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|46246|59444|lyfsjukr|||00|1|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||46246||46246|59444 543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|91867|116242|lyfsjukr|||00|1|0|2|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||91867||91867|116242 543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|167031|209821|lyfsjukr|||00|1|0|4|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||167031||167031|209821 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|24761|33012|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|Follitrópín alfa||24761||24761|33012 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|738|1842|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||738||738|1842 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1279|2576|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1279||1279|2576 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3400|5454|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3400||3400|5454 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|32477|42619|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||32477||32477|42619 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|26184|34784|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||26184||26184|34784 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|32668|42857|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||32668||32668|42857 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|27753|36737|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||27753||27753|36737 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6004|8988|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||6004||6004|8988 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyflausa|||23|60|0|15|Vistor hf|Orion Corporation|Súkralfat||||| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|10301|14692|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||10301||10301|14692 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3395|4861|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3395||3395|4861 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|9211|13340|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||9211||9211|13340 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|57266|73481|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|Follitrópín beta||57266||57266|73481 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4731|7261|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|Follitrópín beta||4731||4731|7261 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|23027|30854|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|Follitrópín beta||23027||23027|30854 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18473|25184|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|Sibutramin||18473||18473|25184 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|18473|25184|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|Sibutramin||18473||18473|25184 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2255|3229|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2255||2255|3229 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5757|8653|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||5757||5757|8653 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|15716|21751|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||15716||15716|21751 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|40285|52340|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||40285||40285|52340 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|111469|140646|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||111469||111469|140646 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|8448|12305|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|Halóperídól||8448||8448|12305 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|159823|200847|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||159823||159823|200847 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|2151|3759|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefna­vakar||2151||2151|3759 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|9770|14099|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||9770||9770|14099 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1628|3050|lyfalmen|||03|1|0|3|Vistor hf|Meda AB|Tríamcínólón||1628||1628|3050 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3712|5878|lyfalmen|||00|100|0|50|Vistor hf|Meda AB|Nabúmeton||3712||3712|5878 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|Morfín||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2417|1904|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|Rabeprazól||784||784|1904 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|3808|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|Rabeprazól||2187||2187|3808 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2422|4127|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|Rabeprazól||2422||2422|4127 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|4233|6585|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|Rabeprazól||4233||4233|6585 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|7916|3975|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|Rabeprazól||2310||2310|3975 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3828|6035|lyfalmen|||63|100|0|67|Vistor hf|Bayer HealthCare AG|Nífedipín||3828||3828|6035 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|645|1716|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|Díklófenak||645||645|1716 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|4480|6920|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|Zópíklón||4480||4480|6920 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3754|5935|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3754||3754|5935 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3727|5898|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3727||3727|5898 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2559|4313|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||2559||2559|4313 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4411|6826|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||4411||4411|6826 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7786|15002|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||7786||7786|15002 555607|N06AB0601|Zoloft|mixtúra|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5246|7959|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||5246||5246|7959 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3392|4856|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Elektrólýtar||3392||3392|4856 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6527|9345|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||6527||6527|9345 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5535|7925|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5535||5535|7925 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4077|5837|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||4077||4077|5837 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3791|5428|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||3791||3791|5428 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5238|7949|lyfalmen|V2150|7949|00|100|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5238||5238|7949 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7228|10649|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||7228||7228|10649 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|10213|14700|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||10213||10213|14700 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1715|3168|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1715||1715|3168 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|162375|204024|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|Gadópentetat||162375||162375|204024 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1052|2268|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|Verapamíl||1052||1052|2268 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2088|3674|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|Verapamíl||2088||2088|3674 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1124|2366|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|Tramadól||1124||1124|2366 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|630|1695|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|Tramadól||630||630|1695 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1758|3226|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|Tramadól||1758||1758|3226 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1011|2212|lyfalmen|V0732|2097|02|10|0|2|Icepharma hf|Grunenthal|Tramadól||1011||1011|2212 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2605|4375|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2605||2605|4375 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6151|9188|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estradíól||6151||6151|9188 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2816|4662|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2816||2816|4662 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3110|5061|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3110||3110|5061 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|10662|15142|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|Desflúran||10662||10662|15142 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1313 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|3069|5005|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3069||3069|5005 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|12083|17228|lyfalmen|||00|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||12083||12083|17228 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1750|3215|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1750||1750|3215 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5849|8778|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5849||5849|8778 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|6342|9447|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6342||6342|9447 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|116317|146682|lyfsjukr|||00|5|0|1|Vistor hf|Abbott Scandinavia AB|Levosimendan||116317||116317|146682 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|613071|575740|lyfsjukr|||00|20|0|5|Vistor hf|Abbott Scandinavia AB|Levosimendan||460942||460942|575740 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2611|4384|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2611||2611|4384 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|35786|46739|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|Mirtazapín||35786||35786|46739 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|26743|35480|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||26743||26743|35480 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|41169|53440|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||41169||41169|53440 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|683|1767|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||683||683|1767 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2118|3715|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2118||2118|3715 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|683|1767|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||683||683|1767 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2118|3715|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2118||2118|3715 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1741|3203|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1741||1741|3203 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|221160|277529|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||221160||221160|277529 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5099|7760|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5099||5099|7760 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5371|8129|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5371||5371|8129 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9488|13716|lyfalmen|||00|98|0|33|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||9488||9488|13716 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|12012|17140|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||12012||12012|17140 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|163094|204920|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|Ribavirin||163094||163094|204920 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6003|8987|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||6003||6003|8987 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|9009|13066|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||9009||9009|13066 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1593|3002|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1593||1593|3002 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|12409|17634|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Olsalazín||12409||12409|17634 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1458|2819|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|Brinzólamíð||1458||1458|2819 566661|L04AB0101|Enbrel|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|87750|111116|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||87750||87750|111116 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|6211|9269|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||6211||6211|9269 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1587|2994|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1587||1587|2994 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|8015|11717|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||||8015|11717 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|6346|9452|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||6346||6346|9452 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|6062|9067|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|Risperídón||6062||6062|9067 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|13345|18800|lyfalmen|V0793|8270|00|60|0|24|Vistor hf|Janssen-Cilag AB|Risperídón||13345||13345|18800 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|22181|29800|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|Risperídón||22181||22181|29800 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|29390|38776|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|Risperídón||29390||29390|38776 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998|30.04.2009|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|18936|25760|lyfalmen|||00|98|0|131|Vistor hf|Bristol-Myers Squibb|Pravastatín||18936||18936|25760 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||14023||14023|19326 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5568||5568|7972 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|16169|8520|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|Rabeprazól||5659||5659|8520 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|2164|3777|lyfalmen|V2072|3445|00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||2164||2164|3777 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1097|2329|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1097||1097|2329 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|Felódipín||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|19107|25656|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||19107||19107|25656 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|19107|25656|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||19107||19107|25656 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2468|4190|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2468||2468|4190 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3515|5610|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3515||3515|5610 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|132587|166938|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|Fíbrínógen manna||132587||132587|166938 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|173548|217935|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|Fíbrínógen manna||173548||173548|217935 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|326488|408345|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|Fíbrínógen manna||326488||326488|408345 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3606|5734|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|Estradíól||3606||3606|5734 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|109743|138498|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|Trastuzumab||109743||109743|138498 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|28103|36856|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|Meropenem||28103||28103|36856 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|55003|70346|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|Meropenem||55003||55003|70346 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|3864|3590|lyfalmen|V0931|2428|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||2026||2026|3590 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|12781|9819|lyfalmen|V0933|6361|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||6616||6616|9819 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|6627|5452|lyfalmen|V0935|3559|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||3398||3398|5452 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|20847|16016|lyfalmen|V0937|10351|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||11183||11183|16016 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0|Icepharma hf|Norpharma |Malatíón||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|6141|8792|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|Adenósín||6141||6141|8792 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|101832|128648|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|Infliximab||101832||101832|128648 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|6854|10142|lyfalmen|||00|28|0|14|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||6854||6854|10142 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2996|4906|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||2996||2996|4906 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1166|2423|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|Terbútalín||1166||1166|2423 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|889|2047|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|Metótrexat||889||889|2047 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|32977|42924|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||32977||32977|42924 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|65657|83610|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||65657||65657|83610 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|125829|158525|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||125829||125829|158525 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5336|9234|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||5336||5336|9234 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|20108|34798|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||20108||20108|34798 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||39554||39554|51112 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||70812||70812|90028 582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001|30.04.2009|R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|425|1417|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Metóprólól||425||425|1417 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|726|1826|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|Metóprólól||726||726|1826 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||53298||53298|68224 583443|C07AA0704|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1057|2275|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Sótalól||1057||1057|2275 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||82356||82356|104401 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||61388||61388|78296 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||92841||92841|117455 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4085|5849|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Elektrólýtar||4085||4085|5849 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2127|3045|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2127||2127|3045 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7855|11246|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||7855||7855|11246 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6444|9226|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Kolvetni||6444||6444|9226 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3130|4481|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3130||3130|4481 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8947|12810|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Kolvetni||8947||8947|12810 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3540|5068|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3540||3540|5068 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4219|6041|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4219||4219|6041 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2386|3416|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2386||2386|3416 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0|Icepharma hf|Fresenius Kabi|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|3640|5780|lyfalmen|||64|30|0|30|Vistor hf|Meda AS|Móklóbemíð||3640||3640|5780 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10681|15165|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|Heparín||10681||10681|15165 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3891|5571|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|Heparín||3891||3891|5571 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|38230|49464|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|Imipenem og ensímhemill||38230||38230|49464 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3642|5783|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3642||3642|5783 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|37045|48306|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||37045||37045|48306 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2818|4665|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2818||2818|4665 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3316|4748|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3316||3316|4748 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1476|2843|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1476||1476|2843 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2349|4028|lyfalmen|V0426|3963|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2349||2349|4028 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|13030|18407|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||13030||13030|18407 588723|B03AA0702|Ferlen-R|forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|60|0|30|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|9402|13599|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9402||9402|13599 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6520|11283|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||6520||6520|11283 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2527|4373|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2527||2527|4373 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6291|10887|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||6291||6291|10887 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3398|5880|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3398||3398|5880 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3529|6107|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3529||3529|6107 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2734|4731|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2734||2734|4731 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|146415|184154|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||146415||146415|184154 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|91930|116320|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|Ritonavír||91930||91930|116320 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|20|Vistor hf|Bayer A/S|Klótrímazól||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Ýmis lyf||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|28390|37531|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||28390||28390|37531 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|209365|262527|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|Tenekteplasi||209365||209365|262527 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||31979||31979|41681 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||36833||36833|47725 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3484|4988|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||3484||3484|4988 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|6716|9954|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|Kalcítríól||6716||6716|9954 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|694|1782|lyfalmen|||00|50|0|3|Icepharma hf|Roche|Klónazepam||694||694|1782 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1084|2311|lyfalmen|||00|150|0|9|Icepharma hf|Roche|Klónazepam||1084||1084|2311 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1841|3339|lyfalmen|||00|100|0|25|Icepharma hf|Roche|Klónazepam||1841||1841|3339 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|19084|25945|lyfalmen|||03|12|0|32|Vistor hf|Meda AB|Tríamcínólón||19084||19084|25945 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||626 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||5211 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3056|4375|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3056||3056|4375 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1097|2165|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1097||1097|2165 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|9328|13355|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||9328||9328|13355 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|621|1683|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||621||621|1683 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4162|6488|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||4162||4162|6488 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991||L|A|5|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|983|2174|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||983||983|2174 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1218|2493|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1218||1218|2493 907024|A04AD0501|Vogalene|eþ-stil|5|mg|10|stk|1|pakki||A04AD05|01.01.1998|31.03.2009|R|A||0|0|E|0|PCO|0|0|1|100|IKR|1597|3008|lyfalmen|||00|10|1|3|Distica|Distica - óskráð lyf|||1597||1597|3008 908048|J07AM5201|Immunoglob. mot tetanus|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|9865|14228|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||9865||9865|14228 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4276|6643|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4276||4276|6643 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2314||2314|3981 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3294|4716|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3294||3294|4716 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2064|2955|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||2064||2064|2955 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12013|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||8233||8233|12013 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3242|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||1770||1770|3242 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|GBP|4671|7179|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||4671||4671|7179 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6365|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||4071||4071|6365 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|10884|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||7401||7401|10884 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|11596|16577|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||11596||11596|16577 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Distica|Distica - óskráð lyf|Estradíól||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Distica|Distica - óskráð lyf|Estradíól||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Distica|Distica - óskráð lyf|Estradíól||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Distica|Distica - óskráð lyf|Testósterón||1837||1837|3333 942468|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998|31.03.2009|R|A||0|0|E|0|PCO|0|0|1|100|IKR|3163|5133|lyfalmen|||00|20|1|20|Distica|Distica - óskráð lyf|||3163||3163|5133 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Distica|Distica - óskráð lyf|Testósterón||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||10030||10030|14355 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1533|2921|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1533||1533|2921 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|3952|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|3952 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947690|C01CA2403|Adrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA24|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1301|2606|lyfalmen|||00|10|1|20|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||1301||1301|2606 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3625|5760|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3625||3625|5760 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3651|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3651 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1307||1307|1871 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|755|1865|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||755||755|1865 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4952|7090|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||4952||4952|7090 952251|J01CA0101|Ampicillin|sts|0| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952798|A03BA0101|Atropin|stl|1|mg/ml|1|ml|10|lykjur||A03BA01|01.07.2004||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1315|2625|lyfalmen|||00|10|1|7|Parlogis hf|Parlogis - óskráð lyf|||1315||1315|2625 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|Morfín||3127||3127|5084 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1410|2754|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1410||1410|2754 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|848|1991|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||848||848|1991 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|16941|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|16941 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|12918|17950|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||12918||12918|17950 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2108|3701|lyfalmen|||00|20|1|20|Parlogis hf|Parlogis - óskráð lyf|||||2108|3701 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4400|6811|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||4400||4400|6811 962523|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|10|fl||B05BB01|01.05.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|5430|7774|lyfsjukr|||0|1000|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||5430||5430|7774